RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: rheumatoid arthritis
Accession: DOID:7148
browse the term
Definition: An arthritis that is an autoimmune disease which attacks healthy cells and tissue located_in joint. (DO)
Synonyms: exact_synonym: RA; atrophic arthritis; rheumatic arthritis or polyarthritis
narrow_synonym: ACPA-negative rheumatoid arthritis; ACPA-positive rheumatoid arthritis; RHEUMATOID ARTHRITIS, PROGRESSION OF; SLC22A4-RELATED CONDITION
related_synonym: rheumatoid arthritis, susceptibility to
primary_id: MESH:D001172
alt_id: MIM:180300
xref: EFO:0000685 ; EFO:0009459 ; EFO:0009460 ; ICD10CM:M06.9 ; ICD9CM:714.0 ; NCI:C2884
For additional species annotation, visit the
Alliance of Genome Resources .
G
A2m
alpha-2-macroglobulin
ISO
GAD
PMID:15118671
RGD:1331525
NCBI chr 4:154,897,770...154,947,787
Ensembl chr 4:154,897,877...154,947,786
G
Abcb1a
ATP binding cassette subfamily B member 1A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20080907 PMID:22104130
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
G
Abcc2
ATP binding cassette subfamily C member 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23897011
NCBI chr 1:242,664,657...242,723,239
Ensembl chr 1:242,664,657...242,723,238
G
Abcc3
ATP binding cassette subfamily C member 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23897011
NCBI chr10:79,296,681...79,342,749
Ensembl chr10:79,296,693...79,342,595
G
Abcc4
ATP binding cassette subfamily C member 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23897011
NCBI chr15:95,541,186...95,774,898
Ensembl chr15:95,542,315...95,774,283
G
Abcc5
ATP binding cassette subfamily C member 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23897011
NCBI chr11:80,473,809...80,567,257
Ensembl chr11:80,473,872...80,567,253
G
Abcg2
ATP binding cassette subfamily G member 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23897011
NCBI chr 4:87,676,241...87,802,757
Ensembl chr 4:87,745,319...87,802,409
G
Acan
aggrecan
disease_progression
ISO
CTD Direct Evidence: marker/mechanism protein:increased degradation:cartilage
CTD RGD
PMID:15292528 PMID:16507130
RGD:11570537
NCBI chr 1:132,981,582...133,044,416
Ensembl chr 1:132,981,582...133,043,627
G
Ackr3
atypical chemokine receptor 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19192274
NCBI chr 9:90,799,682...90,811,246
Ensembl chr 9:90,799,686...90,811,237
G
Adamts4
ADAM metallopeptidase with thrombospondin type 1 motif, 4
ISO
mRNA:increased expression:synovium
RGD
PMID:11801682
RGD:10043106
NCBI chr13:83,670,556...83,680,045
Ensembl chr13:83,670,183...83,680,065
G
Adamts5
ADAM metallopeptidase with thrombospondin type 1 motif, 5
ISO
protein:alternative form:synovium
RGD
PMID:11801682
RGD:10043106
NCBI chr11:25,000,627...25,047,205
Ensembl chr11:25,000,637...25,047,205
G
Adipoq
adiponectin, C1Q and collagen domain containing
ISO
protein:increased expression:serum CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:12833524 PMID:21789720
RGD:5686424
NCBI chr11:77,721,912...77,735,644
Ensembl chr11:77,721,912...77,735,564
G
Adora2a
adenosine A2a receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19192274
NCBI chr20:13,315,848...13,333,386
Ensembl chr20:13,315,853...13,333,386
G
Adrb3
adrenoceptor beta 3
ISO
DNA:missense mutation:cds:p.W64R rs4994 (human)
RGD
PMID:12739037
RGD:5684893
NCBI chr16:64,839,820...64,844,552
Ensembl chr16:64,841,788...64,844,552
G
Aff3
ALF transcription elongation factor 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20453842 PMID:23143596
NCBI chr 9:40,399,099...40,856,716
Ensembl chr 9:40,404,375...40,857,247
G
Ager
advanced glycosylation end product-specific receptor
ISO
protein:decreased expression:plasma (human) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:16385501 PMID:20541603
RGD:7244141
NCBI chr20:4,148,150...4,151,361
Ensembl chr20:4,147,890...4,151,078
G
Ahr
aryl hydrocarbon receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18617548
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
G
Alox5
arachidonate 5-lipoxygenase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12833524
NCBI chr 4:149,531,329...149,578,696
Ensembl chr 4:149,531,515...149,578,743
G
Ang
angiogenin
ISO
RGD
PMID:12653852
RGD:6892721
NCBI chr15:24,312,711...24,323,361
G
Ankrd55
ankyrin repeat domain 55
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23143596
NCBI chr 2:43,883,877...43,983,820
Ensembl chr 2:43,883,857...43,983,680
G
Anxa3
annexin A3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22446963
NCBI chr14:12,727,708...12,781,717
Ensembl chr14:12,719,795...12,781,617
G
Apoa4
apolipoprotein A4
ISO
protein:increased expression:blood serum (human)
RGD
PMID:20367977
RGD:5685646
NCBI chr 8:46,539,083...46,541,464
Ensembl chr 8:46,539,082...46,541,469
G
Arid5b
AT-rich interaction domain 5B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22446963 PMID:23143596
NCBI chr20:20,307,731...20,490,746
Ensembl chr20:20,307,731...20,487,433
G
Atic
5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19193698
NCBI chr 9:73,164,846...73,184,897
Ensembl chr 9:73,164,846...73,184,889
G
Azgp1
alpha-2-glycoprotein 1, zinc-binding
IEP
mRNA:decreased expression:liver
RGD
PMID:18372237
RGD:153352318
NCBI chr12:16,930,990...16,939,333
Ensembl chr12:16,931,024...16,939,091
G
B3gnt2
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22446963
NCBI chr14:96,808,473...96,833,674
Ensembl chr14:96,806,664...96,835,273
G
B3gnt9
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17379860
NCBI chr19:33,129,740...33,134,048
Ensembl chr19:33,128,142...33,132,344
G
Baiap2l1
BAR/IMD domain containing adaptor protein 2 like 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17568789
NCBI chr12:10,250,434...10,339,937
Ensembl chr12:10,250,473...10,339,928
G
Bcl2a1
BCL2-related protein A1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19192274
NCBI chr 8:89,716,914...89,724,998
Ensembl chr 8:89,716,914...89,724,998
G
Bdkrb2
bradykinin receptor B2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12833524
NCBI chr 6:124,472,317...124,502,497
Ensembl chr 6:124,472,566...124,502,497
G
Bglap
bone gamma-carboxyglutamate protein
ISO
protein:increased expression:serum
RGD
PMID:22447331 PMID:3488088
RGD:6483593 , RGD:6483600
NCBI chr 2:173,838,518...173,839,495
Ensembl chr 2:173,838,518...173,839,495
G
Bgn
biglycan
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15292528
NCBI chr X:151,197,296...151,209,458
Ensembl chr X:151,197,273...151,209,461
G
Blk
BLK proto-oncogene, Src family tyrosine kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20453842 PMID:23143596
NCBI chr15:37,626,746...37,665,053
Ensembl chr15:37,627,039...37,665,031
G
Bmp4
bone morphogenetic protein 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20008919
NCBI chr15:19,618,538...19,633,494
Ensembl chr15:19,618,542...19,623,306
G
Bmp6
bone morphogenetic protein 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20008919
NCBI chr17:26,318,121...26,469,691
Ensembl chr17:26,318,569...26,470,365
G
Btnl2
butyrophilin-like 2
susceptibility
ISO
DNA:SNPs: :
RGD
PMID:23364395
RGD:9685033
NCBI chr20:4,490,169...4,504,002
Ensembl chr20:4,489,517...4,503,341
G
C3
complement C3
ISO
RGD
PMID:7561187
RGD:11040775
NCBI chr 9:2,087,437...2,114,366
Ensembl chr 9:2,087,437...2,114,429
G
C4b
complement C4B
ISO
RGD
PMID:22076784
RGD:5688263
NCBI chr20:4,197,371...4,211,684
Ensembl chr20:4,197,366...4,211,681
G
Cald1
caldesmon 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15292528
NCBI chr 4:63,265,781...63,446,938
Ensembl chr 4:63,265,942...63,446,932
G
Casp7
caspase 7
ISO
RGD
PMID:18785314
RGD:5684540
NCBI chr 1:255,437,438...255,476,737
Ensembl chr 1:255,437,172...255,476,729
G
Cast
calpastatin
ISO
RGD
PMID:7706496
RGD:5683620
NCBI chr 2:3,973,112...4,082,658
Ensembl chr 2:3,973,112...4,082,659
G
Cat
catalase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22450443
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
G
Cav2
caveolin 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17379860
NCBI chr 4:45,616,766...45,624,144
Ensembl chr 4:45,616,712...45,624,244
G
Ccl2
C-C motif chemokine ligand 2
ISO
protein:increased expression:serum
RGD
PMID:20056091
RGD:4891442
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
G
Ccl21
C-C motif chemokine ligand 21
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18794853 PMID:20453842 PMID:23143596
NCBI chr 5:56,980,557...56,981,661
Ensembl chr 5:56,980,558...56,981,686
G
Ccl22
C-C motif chemokine ligand 22
ISO
protein:increased expression:plasma:
RGD
PMID:19942450
RGD:10054497
NCBI chr19:10,257,602...10,264,373
Ensembl chr19:10,257,601...10,264,400
G
Ccn1
cellular communication network factor 1
ISO
CTD Direct Evidence: marker/mechanism protein:increased expression:blood serum (human)
CTD RGD
PMID:19192274 PMID:34031328
RGD:329845561
NCBI chr 2:234,562,410...234,565,370
Ensembl chr 2:234,562,408...234,565,484
G
Ccn2
cellular communication network factor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19192274
NCBI chr 1:20,802,199...20,805,315
Ensembl chr 1:20,802,199...20,805,734
G
Ccr1
C-C motif chemokine receptor 1
ISO
RGD
PMID:12860725
RGD:5688170
NCBI chr 8:123,556,286...123,561,841
G
Ccr3
C-C motif chemokine receptor 3
ISO
protein:increased expression:synovial fluid, neutrophil
RGD
PMID:19017998
RGD:4145632
NCBI chr 8:123,586,100...123,634,178
Ensembl chr 8:123,616,236...123,634,990
G
Ccr4
C-C motif chemokine receptor 4
ISO
protein:increased expression:synovial membrane: mRNA:increased expression:synovium:
RGD
PMID:19942450 PMID:25430645
RGD:10054497 , RGD:10054499
NCBI chr 8:114,176,291...114,182,033
Ensembl chr 8:114,176,974...114,178,056
G
Ccr5
C-C motif chemokine receptor 5
resistance no_association
ISO
DNA:frameshift mutation:cds:p.S185_T195del rs333 (human)
RGD
PMID:16541097 PMID:17565662
RGD:1626290 , RGD:1626283
NCBI chr 8:123,752,423...123,757,538
Ensembl chr 8:123,752,325...123,759,260
G
Ccr6
C-C motif chemokine receptor 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20453841 PMID:20453842 PMID:23143596
NCBI chr 1:52,474,477...52,508,301
Ensembl chr 1:52,474,168...52,498,603
G
Cd2
Cd2 molecule
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23143596
NCBI chr 2:188,710,895...188,724,044
Ensembl chr 2:188,710,900...188,724,026
G
Cd244
CD244 molecule
susceptibility
ISO
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Rheumatoid arthritis
CTD OMIM ClinVar
PMID:18794858
NCBI chr13:84,051,339...84,082,864
Ensembl chr13:84,052,493...84,074,492
G
Cd28
Cd28 molecule
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:19898481 PMID:20453842 PMID:23143596 PMID:19075187
RGD:5131619
NCBI chr 9:62,166,324...62,194,674
Ensembl chr 9:62,166,192...62,194,685
G
Cd3e
CD3 epsilon subunit of T-cell receptor complex
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12833524
NCBI chr 8:45,303,848...45,315,005
Ensembl chr 8:45,303,852...45,315,022
G
Cd40
CD40 molecule
ISO
DNA:SNP: :rs4810485 (human) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:18794853 PMID:20453842 PMID:23143596 PMID:20498205
RGD:5490972
NCBI chr 3:153,790,372...153,805,279
Ensembl chr 3:153,790,449...153,805,534
G
Cd5
Cd5 molecule
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23143596
NCBI chr 1:207,365,337...207,386,313
Ensembl chr 1:207,365,337...207,386,313
G
Cd80
Cd80 molecule
ISO
protein:increased expression:serum
RGD
PMID:22917707
RGD:6893647
NCBI chr11:62,254,543...62,293,414
Ensembl chr11:62,254,624...62,292,030
G
Cd83
CD83 molecule
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22446963
NCBI chr17:20,887,309...20,907,009
Ensembl chr17:20,887,309...20,907,083
G
Cdk6
cyclin-dependent kinase 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18794853
NCBI chr 4:30,637,650...30,829,688
Ensembl chr 4:30,646,460...30,829,634
G
Cebpb
CCAAT/enhancer binding protein beta
ISO
protein:increased expression:knee, articular cartilage (human)
RGD
PMID:19248099
RGD:10401213
NCBI chr 3:156,398,035...156,399,466
Ensembl chr 3:156,397,052...156,399,473
G
Chi3l1
chitinase 3 like 1
severity
ISO
protein:increased secretion:serum (human)
RGD
PMID:10461474
RGD:4892605
NCBI chr13:45,641,802...45,649,787
Ensembl chr13:45,641,802...45,649,787
G
Chrna7
cholinergic receptor nicotinic alpha 7 subunit
IEP
mRNA,protein:increased expression:joint, spleen:
RGD
PMID:31279484
RGD:151676715
NCBI chr 1:116,711,559...116,837,269
Ensembl chr 1:116,714,711...116,837,240
G
Chrng
cholinergic receptor nicotinic gamma subunit
ISO
ClinVar Annotator: match by term: Rheumatoid arthritis
ClinVar
PMID:23261301 PMID:25741868 PMID:28492532
NCBI chr 9:87,878,085...87,884,193
Ensembl chr 9:87,878,085...87,914,482
G
Ciita
class II, major histocompatibility complex, transactivator
susceptibility no_association
ISO
DNA:haplotype:promoter/CDS:rs3087456G/rs4774C (human) CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: RHEUMATOID ARTHRITIS, SUSCEPTIBILITY TO | ClinVar Annotator: match by term: Rheumatoid arthritis DNA:polymorphism:promoter:-168A>G (human) DNA:polymorphism:promoter:rs3087456, no association in a German cohort (Human)
OMIM CTD ClinVar RGD
PMID:15821736 PMID:16849401 PMID:25741868 PMID:28492532 PMID:19221398 PMID:15821736 PMID:16426246 More...
RGD:5491176 , RGD:1358146 , RGD:5491189
NCBI chr10:5,139,947...5,187,493
Ensembl chr10:5,140,178...5,187,440
G
Clec12a
C-type lectin domain family 12, member A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17568789
NCBI chr 4:162,798,125...162,816,757
Ensembl chr 4:162,798,125...162,816,753
G
Clec16a
C-type lectin domain containing 16A
ISO
DNA:polymorphism:intron:rs6498169G (human)
RGD
PMID:19221398
RGD:5491176
NCBI chr10:4,927,799...5,123,749
Ensembl chr10:4,928,030...5,123,578
G
Col2a1
collagen type II alpha 1 chain
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27028940 PMID:29935983
NCBI chr 7:129,098,489...129,127,560
Ensembl chr 7:129,098,786...129,127,546
G
Cp
ceruloplasmin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26001728
NCBI chr 2:102,439,433...102,498,075
Ensembl chr 2:102,439,624...102,498,075
G
Crp
C-reactive protein
ISO IDA
protein:increased expression:serum CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:1568518 PMID:22173958 PMID:22173958
RGD:6904209 , RGD:6904209
NCBI chr13:85,135,384...85,175,178
Ensembl chr13:85,124,977...85,175,178
G
Csf2
colony stimulating factor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22446963
NCBI chr10:38,386,945...38,388,926
Ensembl chr10:38,386,945...38,389,199
G
Ctla4
cytotoxic T-lymphocyte-associated protein 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20453842 PMID:23143596
NCBI chr 9:62,318,874...62,325,978
Ensembl chr 9:62,319,312...62,324,963
G
Ctsd
cathepsin D
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12833524
NCBI chr 1:197,527,467...197,539,343
Ensembl chr 1:197,527,467...197,539,488
G
Cx3cl1
C-X3-C motif chemokine ligand 1
ISO
RGD
PMID:11465708
RGD:4892002
NCBI chr19:10,227,337...10,237,826
Ensembl chr19:10,227,340...10,236,833
G
Cxcl2
C-X-C motif chemokine ligand 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15292528
NCBI chr14:17,181,030...17,183,075
Ensembl chr14:17,181,062...17,183,075
G
Cxcl6
C-X-C motif chemokine ligand 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15292528
NCBI chr14:17,310,790...17,312,250
Ensembl chr14:17,310,426...17,313,093
G
Cxcr3
C-X-C motif chemokine receptor 3
ISO
protein:increased expression:synovial fluid, neutrophil
RGD
PMID:19017998
RGD:4145632
NCBI chr X:66,844,318...66,846,969
Ensembl chr X:66,844,318...66,846,969
G
Cxcr4
C-X-C motif chemokine receptor 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19192274
NCBI chr13:40,077,976...40,081,883
Ensembl chr13:40,077,976...40,081,883
G
Cybb
cytochrome b-245 beta chain
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24313545
NCBI chr X:13,358,101...13,392,570
Ensembl chr X:13,359,430...13,392,586
G
Ddit4
DNA-damage-inducible transcript 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17379860
NCBI chr20:27,891,989...27,894,088
Ensembl chr20:27,891,998...27,894,105
G
Ddx6
DEAD-box helicase 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23143596
NCBI chr 8:44,931,127...44,967,773
Ensembl chr 8:44,931,974...44,964,405
G
Dhfr
dihydrofolate reductase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23897011
NCBI chr 2:23,585,876...23,611,199
Ensembl chr 2:23,586,031...23,613,713
G
Dnase1l3
deoxyribonuclease 1L3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23143596 PMID:30224649
NCBI chr15:16,922,335...16,948,322
Ensembl chr15:16,922,335...16,948,317
G
Dnase2
deoxyribonuclease 2, lysosomal
ISS
OMIM:180300
MouseDO
NCBI chr19:23,244,656...23,247,376
Ensembl chr19:23,244,664...23,247,376
G
Dnmt1
DNA methyltransferase 1
severity
ISO
mRNA:increased expression:mononuclear cell
RGD
PMID:20937307
RGD:9588623
NCBI chr 8:19,440,611...19,486,659
Ensembl chr 8:19,440,611...19,486,659
G
Dnmt3b
DNA methyltransferase 3 beta
disease_progression
ISO
DNA:polymorphism:promoter:-283C>T(human)
RGD
PMID:19777235
RGD:9589110
NCBI chr 3:142,130,588...142,169,128
Ensembl chr 3:142,130,592...142,169,124
G
Edn1
endothelin 1
treatment
ISO
RGD
PMID:22249931
RGD:8661695
NCBI chr17:22,454,924...22,460,812
Ensembl chr17:22,454,420...22,460,885
G
Eln
elastin
ISO
RGD
PMID:12643515
RGD:9585739
NCBI chr12:21,968,544...22,011,929
Ensembl chr12:21,968,544...22,011,928
G
Eno1
enolase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19898480
NCBI chr 5:160,719,951...160,731,337
Ensembl chr 5:160,719,951...160,731,336
G
Epas1
endothelial PAS domain protein 1
ISO
protein:increased expression:layer of synovial tissue, stromal cell
RGD
PMID:12823854
RGD:10395366
NCBI chr 6:7,790,236...7,871,717
Ensembl chr 6:7,790,647...7,871,228
G
Esco2
establishment of sister chromatid cohesion N-acetyltransferase 2
ISO
mRNA:increased expression:peripheral blood mononuclear cell
RGD
PMID:36104638
RGD:155791669
NCBI chr15:40,034,566...40,052,295
Ensembl chr15:40,034,568...40,055,306
G
Esr2
estrogen receptor 2
severity
ISO
DNA:SNP:exon:rs1256049(human)
RGD
PMID:21523342
RGD:5508794
NCBI chr 6:94,858,438...94,909,630
Ensembl chr 6:94,809,547...94,908,919
G
F2
coagulation factor II, thrombin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26001728
NCBI chr 3:77,596,196...77,609,486
Ensembl chr 3:77,596,198...77,609,486
G
Fas
Fas cell surface death receptor
susceptibility
ISO
DNA:snp:promoter:g.-670A>G (human) protein:increased expression:serum (human)
RGD
PMID:23053964 PMID:20875116 PMID:12148596
RGD:8662433 , RGD:12903969 , RGD:8662455
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
G
Faslg
Fas ligand
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20008919
NCBI chr13:74,151,519...74,172,760
Ensembl chr13:74,154,954...74,162,215
G
Fcgr1a
Fc gamma receptor 1A
ISO
protein:increased expression:synovial joint:
RGD
PMID:16670289
RGD:9685708
NCBI chr 2:183,851,075...183,860,077
Ensembl chr 2:183,851,077...183,859,994
G
Fcgr2a
Fc gamma receptor 2A
ISO
DNA:polymorphism: :p.H131R (human) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:20453842 PMID:23143596 PMID:12508778 PMID:8254199
RGD:5147978 , RGD:5147984
NCBI chr13:83,280,782...83,297,535
Ensembl chr13:83,280,784...83,295,967
G
Fcgr3a
Fc gamma receptor 3A
susceptibility
ISO
DNA:polymorphism:exon:p.F158V(rs396991)(human) DNA:CNVs protein:decreased expression:NK cell
RGD
PMID:19019892 PMID:25154742 PMID:15334114
RGD:5508391 , RGD:11344974 , RGD:5508467
NCBI chr13:83,249,905...83,259,921
Ensembl chr13:83,249,872...83,259,921
G
Fkbp5
FKBP prolyl isomerase 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12833524
NCBI chr20:6,457,207...6,575,404
Ensembl chr20:6,457,216...6,541,674
G
Foxo3
forkhead box O3
ISO
mRNA,protein:increased expression:peripheral blood mononuclear cell, polymorphonuclear cell,synovium:
RGD
PMID:19435720
RGD:10402186
NCBI chr20:45,669,708...45,764,606
Ensembl chr20:45,672,995...45,764,561
G
Foxp3
forkhead box P3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20476861
NCBI chr X:14,908,494...14,924,994
Ensembl chr X:14,908,494...14,923,838
G
Fpgs
folylpolyglutamate synthase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23897011
NCBI chr 3:15,972,800...15,993,592
Ensembl chr 3:15,972,800...15,993,563
G
Gart
phosphoribosylglycinamide formyltransferase, phosphoribosylglycinamide synthetase, phosphoribosylaminoimidazole synthetase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23897011
NCBI chr11:30,864,896...30,891,125
Ensembl chr11:30,865,889...30,891,125
G
Gata3
GATA binding protein 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23143596
NCBI chr17:68,643,760...68,666,000
Ensembl chr17:68,643,873...68,665,391
G
Gc
GC, vitamin D binding protein
ISO
protein:decreased expression:plasma CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:3874814 PMID:9548303
RGD:5509931
NCBI chr14:18,632,146...18,667,563
Ensembl chr14:18,632,135...18,667,567
G
Gdf5
growth differentiation factor 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18830904
NCBI chr 3:144,454,316...144,458,508
Ensembl chr 3:144,454,338...144,458,612
G
Ggh
gamma-glutamyl hydrolase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23897011
NCBI chr 5:33,529,880...33,552,790
Ensembl chr 5:33,529,880...33,552,787
G
Gin1
gypsy retrotransposon integrase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23143596
NCBI chr 9:98,293,596...98,315,155
Ensembl chr 9:98,293,597...98,315,848
G
Gprc5a
G protein-coupled receptor, class C, group 5, member A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17379860
NCBI chr 4:167,903,542...167,922,276
Ensembl chr 4:167,903,542...167,922,260
G
Grk2
G protein-coupled receptor kinase 2
ISO
DNA: deletion: : heterozygous protein: decreased expression: mononuclear cells CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:10094932 PMID:18662895 PMID:10094932
RGD:5688373 , RGD:5688380
NCBI chr 1:201,580,823...201,601,580
Ensembl chr 1:201,581,480...201,601,582
G
Grk5
G protein-coupled receptor kinase 5
no_association
ISO
DNA: deletion::GRK2 and GRK6 deletions resulted in more severe arthritis protein: decreased expression: mononuclear leukocytes
RGD
PMID:18662895 PMID:10094932
RGD:5688373 , RGD:5688380
NCBI chr 1:260,028,269...260,223,699
Ensembl chr 1:260,028,242...260,218,701
G
Grk6
G protein-coupled receptor kinase 6
ISO
DNA: deletion: : homozygous CTD Direct Evidence: marker/mechanism protein: decreased expression: mononuclear cells
CTD RGD
PMID:10094932 PMID:18662895 PMID:10094932
RGD:5688373 , RGD:5688380
NCBI chr17:9,177,018...9,192,813
Ensembl chr17:9,177,019...9,192,644
G
Gsdme
gasdermin E
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17379860
NCBI chr 4:79,258,799...79,321,129
Ensembl chr 4:79,257,804...79,320,806
G
Gstm1
glutathione S-transferase mu 1
susceptibility
ISO
DNA:deletion: : DNA:deletion: :
RGD
PMID:16887863 PMID:16870093 PMID:15940757
RGD:5490993 , RGD:5490994 , RGD:5490998
NCBI chr 2:195,649,845...195,655,402
Ensembl chr 2:195,649,845...195,655,411
G
Gstt1
glutathione S-transferase theta 1
severity susceptibility
ISO
DNA:deletion: :
RGD
PMID:19473562 PMID:20401725 PMID:20597111
RGD:5490553 , RGD:5490983 , RGD:5490982
NCBI chr20:12,856,613...12,873,586
Ensembl chr20:12,856,669...12,873,585
G
Hapln1
hyaluronan and proteoglycan link protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17568789
NCBI chr 2:20,631,640...20,696,388
Ensembl chr 2:20,631,640...20,693,777
G
Hcls1
hematopoietic cell specific Lyn substrate 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12833524
NCBI chr11:63,817,482...63,840,943
Ensembl chr11:63,817,476...63,841,014
G
Hdac1
histone deacetylase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32289289
NCBI chr 5:141,853,992...141,881,057
Ensembl chr 5:141,853,989...141,881,111
G
Hfe
homeostatic iron regulator
ISO
DNA:missense mutation: :p.C282Y (rs1800562) (human)
RGD
PMID:30651232
RGD:14746965
NCBI chr17:41,413,451...41,421,502
Ensembl chr17:41,413,451...41,421,502
G
Hgf
hepatocyte growth factor
disease_progression
ISO
protein:increased expression:serum:
RGD
PMID:24387171
RGD:8548659
NCBI chr 4:18,673,736...18,745,582
Ensembl chr 4:18,677,101...18,745,409
G
Hif1a
hypoxia inducible factor 1 subunit alpha
ISO
protein:increased expression:layer of synovial tissue, stromal cell
RGD
PMID:12823854
RGD:10395366
NCBI chr 6:92,624,059...92,669,262
Ensembl chr 6:92,624,390...92,669,261
G
Hnrnpa2b1
heterogeneous nuclear ribonucleoprotein A2/B1
severity
IDA
RGD
PMID:18025202
RGD:9685481
NCBI chr 4:80,534,659...80,545,297
Ensembl chr 4:80,534,651...80,545,249
G
Hoxd10
homeo box D10
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17568789
NCBI chr 3:59,594,516...59,597,725
Ensembl chr 3:59,594,516...59,597,725
G
Hoxd11
homeobox D11
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17568789
NCBI chr 3:59,584,840...59,587,257
Ensembl chr 3:59,585,039...59,586,783
G
Hoxd13
homeo box D13
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17568789
NCBI chr 3:59,570,647...59,573,963
Ensembl chr 3:59,570,646...59,573,963
G
Hsd11b1
hydroxysteroid 11-beta dehydrogenase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19192274
NCBI chr13:104,728,539...104,798,884
Ensembl chr13:104,728,539...104,788,687
G
Hsp90aa1
heat shock protein 90 alpha family class A member 1
ISO
mRNA:increased expression:peripheral blood leukocyte:
RGD
PMID:21417552
RGD:10402843
NCBI chr 6:129,702,376...129,707,907
Ensembl chr 6:129,702,383...129,707,268
G
Hspa4
heat shock protein family A (Hsp70) member 4
ISO
protein:increased expression:peripheral blood lymphocyte (human)
RGD
PMID:22047640
RGD:5688784
NCBI chr10:37,408,025...37,449,080
Ensembl chr10:37,408,025...37,449,001
G
Hspa5
heat shock protein family A (Hsp70) member 5
ISO
protein:increased expression:synovial joint
RGD
PMID:11315915
RGD:5685639
NCBI chr 3:18,055,507...18,059,969
Ensembl chr 3:18,055,405...18,059,891
G
Hspa9
heat shock protein family A (Hsp70) member 9
ISO
protein:increased expression:synovial cell:
RGD
PMID:23739258
RGD:10402561
NCBI chr18:26,536,131...26,554,294
Ensembl chr18:26,535,798...26,554,292
G
Hspb1
heat shock protein family B (small) member 1
ISO
protein:increased expression:serum:
RGD
PMID:21417552
RGD:10402843
NCBI chr12:20,794,014...20,795,675
Ensembl chr12:20,794,028...20,795,743
G
Hspd1
heat shock protein family D (Hsp60) member 1
ISO
mRNA:increased expression:peripheral blood leukocyte:
RGD
PMID:21417552
RGD:10402843
NCBI chr 9:56,579,195...56,590,011
Ensembl chr 9:56,579,201...56,589,662
G
Ifng
interferon gamma
treatment
ISO
mRNA:increased expression:synovial (human) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:22450443 PMID:1417133 PMID:22660635
RGD:8157623 , RGD:155663483
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
G
Igf2
insulin-like growth factor 2
ISO
DNA:loss of imprinting:synovial cell protein:decreased expression:plasma
RGD
PMID:19556211 PMID:11247331
RGD:5510001 , RGD:5510014
NCBI chr 1:197,814,409...197,831,802
Ensembl chr 1:197,814,410...197,823,018
G
Igfbp3
insulin-like growth factor binding protein 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17379860
NCBI chr14:82,056,347...82,064,083
Ensembl chr14:82,056,347...82,064,083
G
Ikzf3
IKAROS family zinc finger 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23143596
NCBI chr10:83,460,564...83,553,591
Ensembl chr10:83,465,745...83,553,591
G
Il10
interleukin 10
susceptibility
ISO
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: RHEUMATOID ARTHRITIS, SUSCEPTIBILITY TO | ClinVar Annotator: match by term: Rheumatoid arthritis, progression of
CTD OMIM ClinVar
PMID:12847677 PMID:22450443 PMID:25741868 PMID:28492532
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
G
Il13
interleukin 13
ISO
protein:increased expression:serum
RGD
PMID:12051401
RGD:8549582
NCBI chr10:37,790,130...37,792,687
Ensembl chr10:37,790,130...37,792,737
G
Il17a
interleukin 17A
treatment
ISO
mRNA:increased expression:synovial (human)
RGD
PMID:20926833 PMID:22660635
RGD:9068415 , RGD:155663483
NCBI chr 9:23,144,402...23,147,889
Ensembl chr 9:23,144,402...23,147,889
G
Il18
interleukin 18
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16368150
NCBI chr 8:50,904,630...50,932,887
Ensembl chr 8:50,906,960...50,932,887
G
Il19
interleukin 19
ISO
ClinVar Annotator: match by term: RHEUMATOID ARTHRITIS, SUSCEPTIBILITY TO | ClinVar Annotator: match by term: Rheumatoid arthritis, progression of
ClinVar
PMID:12847677 PMID:25741868 PMID:28492532
NCBI chr13:42,397,715...42,411,637
Ensembl chr13:42,399,138...42,405,473
G
Il1a
interleukin 1 alpha
severity
ISO
associated with lung disease, interstitial protein:increased expression:plasma, synovial fluid
RGD
PMID:11192540 PMID:8162643
RGD:4142818 , RGD:7794716
NCBI chr 3:116,526,601...116,537,055
Ensembl chr 3:116,526,604...116,536,822
G
Il1b
interleukin 1 beta
ISO
protein:decreased expression:serum mRNA:increased expression:synovial (human) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:12566094 PMID:17379860 PMID:22450443 PMID:22414257 PMID:22660635
RGD:6482656 , RGD:155663483
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il1rn
interleukin 1 receptor antagonist
ISO
CTD Direct Evidence: marker/mechanism|therapeutic
CTD RGD
PMID:7706905 PMID:19192274 PMID:19447938 PMID:10637275
RGD:7174696 , RGD:8549810
NCBI chr 3:7,111,567...7,127,451
Ensembl chr 3:7,111,550...7,127,445
G
Il2
interleukin 2
ISO
RGD
PMID:6421522
RGD:8662948
NCBI chr 2:120,004,862...120,009,566
Ensembl chr 2:120,004,862...120,009,566
G
Il20
interleukin 20
ISO
RGD
PMID:16947773
RGD:5147395
NCBI chr13:42,380,981...42,384,625
Ensembl chr13:42,380,981...42,384,625
G
Il21r
interleukin 21 receptor
ISO
RGD
PMID:19342640
RGD:6892964
NCBI chr 1:180,168,028...180,195,690
Ensembl chr 1:180,168,097...180,195,522
G
Il23a
interleukin 23 subunit alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19192274
NCBI chr 7:721,809...723,923
Ensembl chr 7:721,809...723,923
G
Il23r
interleukin 23 receptor
susceptibility
ISO
DNA:SNP::rs1343151(human)
RGD
PMID:18647855
RGD:8549596
NCBI chr 4:96,580,568...96,672,540
Ensembl chr 4:96,580,714...96,674,021
G
Il2ra
interleukin 2 receptor subunit alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20453842 PMID:20476861 PMID:23143596
NCBI chr17:66,849,974...66,898,665
Ensembl chr17:66,849,974...66,898,697
G
Il2rb
interleukin 2 receptor subunit beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20453842 PMID:23143596
NCBI chr 7:110,033,341...110,048,054
Ensembl chr 7:110,033,341...110,048,054
G
Il3
interleukin 3
ISO
DNA: SNPs: Multiple: gene-gene interaction
RGD
PMID:20018070
RGD:5686905
NCBI chr10:38,405,716...38,408,066
Ensembl chr10:38,405,716...38,408,066
G
Il4r
interleukin 4 receptor
severity
ISO
DNA:SNP: :rs1805010 (human)
RGD
PMID:24782180
RGD:10402783
NCBI chr 1:180,115,061...180,139,981
Ensembl chr 1:180,115,120...180,139,980
G
Il5
interleukin 5
ISO
RGD
PMID:22293286
RGD:5687156
NCBI chr10:37,874,342...37,877,213
Ensembl chr10:37,874,342...37,877,213
G
Il6
interleukin 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19192274 PMID:22450443
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Il6r
interleukin 6 receptor
ISO
CTD Direct Evidence: marker/mechanism|therapeutic
CTD
PMID:16729287 PMID:23143596
NCBI chr 2:175,289,157...175,347,719
Ensembl chr 2:175,298,686...175,347,536
G
Il6st
interleukin 6 cytokine family signal transducer
ISO ISS
CTD Direct Evidence: marker/mechanism OMIM:180300
CTD MouseDO
PMID:20453842
NCBI chr 2:44,065,979...44,106,255
Ensembl chr 2:44,066,130...44,109,936
G
Irak1
interleukin-1 receptor-associated kinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23143596
NCBI chr X:151,768,621...151,778,521
Ensembl chr X:151,768,777...151,778,521
G
Irf5
interferon regulatory factor 5
ISO
ClinVar Annotator: match by term: Rheumatoid arthritis CTD Direct Evidence: marker/mechanism
ClinVar CTD RGD
PMID:15657875 PMID:16642019 PMID:17599733 PMID:18063667 PMID:20453842 PMID:23143596 PMID:29379122 PMID:29352853 More...
RGD:40924627 , RGD:40924559
NCBI chr 4:58,127,577...58,140,665
Ensembl chr 4:58,127,640...58,139,267
G
Irf8
interferon regulatory factor 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23143596
NCBI chr19:48,790,581...48,812,363
Ensembl chr19:48,790,588...48,811,829
G
Itga6
integrin subunit alpha 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17379860
NCBI chr 3:56,604,512...56,689,428
Ensembl chr 3:56,617,268...56,689,428
G
Itpa
inosine triphosphatase
treatment
ISO
DNA:SNP: :94C>A(human)
RGD
PMID:29441893
RGD:14975307
NCBI chr 3:117,885,464...117,897,247
Ensembl chr 3:117,885,099...117,897,249
G
Jak2
Janus kinase 2
ISO
RGD
PMID:21510883
RGD:6483024
NCBI chr 1:226,995,334...227,054,381
Ensembl chr 1:226,995,334...227,054,189
G
Kat2b
lysine acetyltransferase 2B
ISO
mRNA:increased expression:peripheral blood mononuclear cell
RGD
PMID:36104638
RGD:155791669
NCBI chr 9:6,562,525...6,667,064
Ensembl chr 9:6,562,288...6,667,064
G
Kif5a
kinesin family member 5A
susceptibility
ISO
CTD Direct Evidence: marker/mechanism DNA:snps:intron, 3' utr:c.2756-43A>C, c.*776C>T (rs775246, rs775251) (human) DNA:snp:intron:c.1717-152C>G (rs1678542) (human)
CTD RGD
PMID:23143596 PMID:21784728 PMID:23378462
RGD:12793073 , RGD:12793072
NCBI chr 7:63,051,894...63,089,024
Ensembl chr 7:63,049,424...63,092,858
G
Kmt2c
lysine methyltransferase 2C
treatment
IMP
RGD
PMID:33914205
RGD:151356764
NCBI chr 4:9,620,638...9,834,787
Ensembl chr 4:9,609,627...9,833,539
G
Lcn2
lipocalin 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:7554268
NCBI chr 3:15,680,688...15,684,033
Ensembl chr 3:15,680,687...15,684,095
G
Lhx2
LIM homeobox 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17568789
NCBI chr 3:22,113,619...22,143,909
Ensembl chr 3:22,126,007...22,143,908
G
Lrrk2
leucine-rich repeat kinase 2
ISO
RGD
PMID:17082220
RGD:5508419
NCBI chr 7:122,826,696...122,987,711
Ensembl chr 7:122,826,696...122,987,703
G
Ly96
lymphocyte antigen 96
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17379860
NCBI chr 5:2,582,233...2,612,357
Ensembl chr 5:2,582,254...2,612,386
G
Mab21l2
mab-21 like 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17568789
NCBI chr 2:171,946,573...171,949,655
Ensembl chr 2:171,946,573...171,949,655
G
Marcks
myristoylated alanine rich protein kinase C substrate
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19192274
NCBI chr20:40,685,315...40,691,012
Ensembl chr20:40,685,315...40,691,012
G
Mbd2
methyl-CpG binding domain protein 2
ISO
mRNA:increased expression:mononuclear cell
RGD
PMID:20937307
RGD:9588623
NCBI chr18:64,174,002...64,240,795
Ensembl chr18:64,174,002...64,240,794
G
Mbd4
methyl-CpG binding domain 4 DNA glycosylase
susceptibility no_association
ISO
DNA:snps:introns:IVS5-140A>G (rs3138355), IVS6-218C>T (rs2005618) (human) DNA:snps:cds, intron:p.E346K, IVS6-218C>T (rs140693, rs2005618) (human)
RGD
PMID:20676650 PMID:22505706
RGD:9588977 , RGD:9588978
NCBI chr 4:148,893,049...148,904,833
Ensembl chr 4:148,894,280...148,904,982
G
Mdk
midkine
ISO
RGD
PMID:15146411
RGD:1581200
NCBI chr 3:77,901,134...77,903,997
Ensembl chr 3:77,901,158...77,903,130
G
Mgarp
mitochondria-localized glutamic acid-rich protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17568789
NCBI chr 2:135,431,283...135,439,425
Ensembl chr 2:135,431,283...135,439,612
G
Mif
macrophage migration inhibitory factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16872482
NCBI chr20:12,790,919...12,791,784
Ensembl chr20:12,790,902...12,799,504
G
Mir146a
microRNA 146a
ISO
mRNA:decreased expression:cartilage tissue (human) mRNA:increased expression:synovial (human)
RGD
PMID:31472145 PMID:22660635
RGD:152177908 , RGD:155663483
NCBI chr10:27,848,516...27,848,610
Ensembl chr10:27,848,516...27,848,610
G
Mir23b
microRNA 23b
ISO
mRNA, protein:decreased expression:synovial (human)
RGD
PMID:22660635
RGD:155663483
NCBI chr17:1,813,667...1,813,763
Ensembl chr17:1,813,667...1,813,763
G
Mmel1
membrane metallo-endopeptidase-like 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23143596
NCBI chr 5:165,431,278...165,461,716
Ensembl chr 5:165,431,343...165,461,716
G
Mmp1
matrix metallopeptidase 1
ISO
protein:increased expression:plasma (human)
RGD
PMID:9972954
RGD:7207129
NCBI chr 8:4,658,588...4,679,099
Ensembl chr 8:4,658,588...4,679,097
G
Mmp10
matrix metallopeptidase 10
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19192274
NCBI chr 8:4,689,840...4,697,748
Ensembl chr 8:4,689,840...4,697,748
G
Mmp12
matrix metallopeptidase 12
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19192274
NCBI chr 8:4,581,785...4,591,687
Ensembl chr 8:4,581,785...4,599,611
G
Mmp14
matrix metallopeptidase 14
ISS
OMIM:180300
MouseDO
NCBI chr15:27,887,795...27,897,020
Ensembl chr15:27,887,727...27,899,864
G
Mmp2
matrix metallopeptidase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16872482
NCBI chr19:14,154,657...14,182,870
Ensembl chr19:14,154,657...14,182,870
G
Mmp3
matrix metallopeptidase 3
disease_progression
ISO
protein:increased expression:serum (human)
RGD
PMID:7639798 PMID:22314025 PMID:11796404
RGD:7207128 , RGD:8693673 , RGD:7241254
NCBI chr 8:4,640,397...4,653,963
Ensembl chr 8:4,640,416...4,653,961
G
Mmp8
matrix metallopeptidase 8
ISO
protein:increased expression:synovial fluid, serum (human)
RGD
PMID:15194590
RGD:7207131
NCBI chr 8:4,724,009...4,733,864
Ensembl chr 8:4,724,029...4,733,520
G
Mmp9
matrix metallopeptidase 9
ISO
RGD
PMID:16406300
RGD:1582623
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
G
Mpo
myeloperoxidase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22450443 PMID:26001728
NCBI chr10:72,594,883...72,608,862
Ensembl chr10:72,594,661...72,604,819
G
Mt-nd1
mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 1
ISO
DNA:missense mutations:cds:multiple (human)
RGD
PMID:15987486
RGD:5490238
NCBI chr MT:2,740...3,694 NCBI chr MT:2,740...3,694 NCBI chr MT:2,740...3,694 NCBI chr MT:2,740...3,694 NCBI chr MT:2,740...3,694 NCBI chr MT:2,740...3,694 NCBI chr MT:2,740...3,694 NCBI chr MT:2,740...3,694 NCBI chr MT:2,740...3,694
Ensembl chr MT:2,740...3,694
G
Mthfr
methylenetetrahydrofolate reductase
ISO
DNA:SNP: :677C>T(human) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:22104130 PMID:23685257
RGD:7387222
NCBI chr 5:158,465,248...158,484,999
Ensembl chr 5:158,465,296...158,483,797
G
Ncf1
neutrophil cytosolic factor 1
induced
ISO IAGP
CTD Direct Evidence: marker/mechanism DNA:polymorphism:M153T (rat)
CTD RGD
PMID:12833524 PMID:28135245 PMID:21275845
RGD:41404729
NCBI chr12:22,485,382...22,494,647
Ensembl chr12:22,485,451...22,494,646
G
Ncf2
neutrophil cytosolic factor 2
ISO
CTD Direct Evidence: marker/mechanism DNA:polymorphism, SNP:cds (rs789181) (human)
CTD RGD
PMID:12833524 PMID:17897462
RGD:41404710
NCBI chr13:64,955,622...64,986,144
Ensembl chr13:64,955,503...64,986,277
G
Ncf4
neutrophil cytosolic factor 4
ISO
DNA:polymorphism, SNP:cds (rs729749) (human)
RGD
PMID:17897462
RGD:41404710
NCBI chr 7:109,825,420...109,843,389
Ensembl chr 7:109,826,020...109,843,389
G
Ndufa4l2
NDUFA4, mitochondrial complex associated like 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19192274
NCBI chr 7:63,351,021...63,359,010
Ensembl chr 7:63,356,883...63,359,010
G
Nfkbie
NFKB inhibitor epsilon
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22446963
NCBI chr 9:15,443,600...15,450,437
Ensembl chr 9:15,436,941...15,450,437
G
Nfkbil1
NFKB inhibitor like 1
susceptibility
ISO
DNA:snp:promoter:c.-132T>A (rs2071592) (human) CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Rheumatoid arthritis
CTD OMIM ClinVar RGD
PMID:12509789 PMID:12509789
RGD:1331681
NCBI chr20:3,589,974...3,608,348
Ensembl chr20:3,590,642...3,605,616
G
Notch4
notch receptor 4
ISO
mRNA : increased expression: : cd4+ cells
RGD
PMID:20132067
RGD:6480790
NCBI chr20:4,160,362...4,184,466
Ensembl chr20:4,160,445...4,184,465
G
Npsr1
neuropeptide S receptor 1
ISO
RGD
PMID:20179762
RGD:4891930
NCBI chr 8:22,606,946...22,831,558
Ensembl chr 8:22,606,946...22,831,558
G
Nr3c1
nuclear receptor subfamily 3, group C, member 1
IEP
mRNA:increased expression:paw
RGD
PMID:18448865
RGD:4892311
NCBI chr18:31,271,681...31,393,320
Ensembl chr18:31,271,681...31,393,375
G
Nr4a3
nuclear receptor subfamily 4, group A, member 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19192274
NCBI chr 5:62,361,588...62,401,489
Ensembl chr 5:62,361,822...62,402,733
G
Oprm1
opioid receptor, mu 1
susceptibility
ISO
DNA:missense mutation:exon:p.N40D (118A>G) (rs 1799971) (human)
RGD
PMID:31309790
RGD:401827955
NCBI chr 1:43,160,057...43,413,409
Ensembl chr 1:43,160,057...43,413,409
G
Padi2
peptidyl arginine deiminase 2
ISO
ClinVar Annotator: match by term: Rheumatoid arthritis
ClinVar
NCBI chr 5:153,209,053...153,251,632
Ensembl chr 5:153,209,053...153,251,632
G
Padi4
peptidyl arginine deiminase 4
ISO
ClinVar Annotator: match by term: Rheumatoid arthritis CTD Direct Evidence: marker/mechanism
ClinVar CTD
PMID:23143596 PMID:25741868
NCBI chr 5:153,041,351...153,074,412
Ensembl chr 5:153,041,352...153,074,362
G
Pdgfb
platelet derived growth factor subunit B
ISO
RGD
PMID:1708827
RGD:6482653
NCBI chr 7:111,539,444...111,557,984
Ensembl chr 7:111,540,345...111,557,984
G
Pgf
placental growth factor
ISO
RGD
PMID:19180491
RGD:6483591
NCBI chr 6:104,816,102...104,826,685
Ensembl chr 6:104,816,104...104,826,685
G
Pik3r1
phosphoinositide-3-kinase regulatory subunit 1
ISO
mRNA:increased expression:cartilage tissue (human)
RGD
PMID:31472145
RGD:152177908
NCBI chr 2:32,878,942...32,963,668
Ensembl chr 2:32,882,032...32,963,631
G
Pla2g7
phospholipase A2 group VII
ISO
RGD
PMID:17326817
RGD:6482776
NCBI chr 9:17,362,214...17,404,476
Ensembl chr 9:17,362,225...17,404,476
G
Plaur
plasminogen activator, urokinase receptor
ISO
RGD
PMID:22011479
RGD:6484117
NCBI chr 1:80,053,440...80,068,384
Ensembl chr 1:80,050,324...80,068,595
G
Plb1
phospholipase B1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24520335
NCBI chr 6:24,087,051...24,227,167
Ensembl chr 6:24,089,214...24,210,117
G
Pld4
phospholipase D family, member 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22446963
NCBI chr 6:131,818,860...131,827,457
Ensembl chr 6:131,818,860...131,826,376
G
Plek
pleckstrin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12833524
NCBI chr14:91,397,015...91,429,693
Ensembl chr14:91,397,019...91,454,131
G
Pon1
paraoxonase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16055108
NCBI chr 4:33,294,737...33,325,759
Ensembl chr 4:33,294,722...33,321,360
G
Pou3f1
POU class 3 homeobox 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23143596
NCBI chr 5:136,910,391...136,913,371
Ensembl chr 5:136,910,391...136,913,371
G
Prdm1
PR/SET domain 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19898481 PMID:20453842 PMID:23143596 PMID:36181686
NCBI chr20:47,959,858...47,981,488
Ensembl chr20:47,959,858...47,981,488
G
Prkcq
protein kinase C, theta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18794853 PMID:20453842 PMID:23143596
NCBI chr17:67,246,394...67,379,049
Ensembl chr17:67,246,394...67,378,704
G
Ptgs1
prostaglandin-endoperoxide synthase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15167967
NCBI chr 3:19,584,015...19,605,589
Ensembl chr 3:19,584,015...19,605,586
G
Ptgs2
prostaglandin-endoperoxide synthase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:11978490 PMID:19192274 PMID:21905970
RGD:5508313
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
G
Ptk2
protein tyrosine kinase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12833524
NCBI chr 7:105,126,725...105,331,848
Ensembl chr 7:105,126,728...105,331,783
G
Ptpn2
protein tyrosine phosphatase, non-receptor type 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22446963
NCBI chr18:61,229,012...61,294,662
Ensembl chr18:61,229,014...61,294,627
G
Ptpn22
protein tyrosine phosphatase, non-receptor type 22
susceptibility no_association
ISO
DNA:snp:cds:p.R620W (rs2476601) (human) ClinVar Annotator: match by term: RHEUMATOID ARTHRITIS, SUSCEPTIBILITY TO | ClinVar Annotator: match by term: Rheumatoid arthritis CTD Direct Evidence: marker/mechanism DNA:SNP::1858C>T (human) DNA:snp:cds:p.R263Q (rs33996649) (human)
ClinVar OMIM CTD RGD
PMID:15004560 PMID:15208781 PMID:15273934 PMID:15580548 PMID:15719322 PMID:15744042 PMID:16273109 PMID:16339849 PMID:16470599 PMID:17170052 PMID:17436241 PMID:17554300 PMID:17878369 PMID:18301444 PMID:18978792 PMID:19265110 PMID:19430480 PMID:19898480 PMID:20453842 PMID:21190368 PMID:21841778 PMID:23143596 PMID:25741868 PMID:28492532 PMID:30224649 PMID:15208781 PMID:21467606 PMID:21279993 More...
RGD:6484535 , RGD:7829746 , RGD:6484595
NCBI chr 2:191,366,761...191,414,782
Ensembl chr 2:191,366,808...191,414,779
G
Ptprc
protein tyrosine phosphatase, receptor type, C
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20453842 PMID:23143596
NCBI chr13:49,596,193...49,708,283
Ensembl chr13:49,596,193...49,708,692
G
Pxk
PX domain containing serine/threonine kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20453842
NCBI chr15:16,759,857...16,828,452
Ensembl chr15:16,759,862...16,828,444
G
Rab8a
RAB8A, member RAS oncogene family
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12833524
NCBI chr16:17,654,027...17,675,385
Ensembl chr16:17,654,034...17,675,678
G
Rap2a
RAP2A, member of RAS oncogene family
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12833524
NCBI chr15:97,596,848...97,597,338
Ensembl chr15:97,596,020...97,624,138
G
Rasgrp1
RAS guanyl releasing protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23143596
NCBI chr 3:104,168,549...104,230,107
Ensembl chr 3:104,170,013...104,230,056
G
Rbpj
recombination signal binding protein for immunoglobulin kappa J region
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20453842 PMID:23143596
NCBI chr14:57,338,493...57,523,330
Ensembl chr14:57,338,507...57,523,353
G
Rcan1
regulator of calcineurin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23143596
NCBI chr11:31,622,208...31,702,150
Ensembl chr11:31,622,210...31,702,045
G
Rel
REL proto-oncogene, NF-kB subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19503088 PMID:20453842 PMID:23143596
NCBI chr14:97,690,105...97,721,194
Ensembl chr14:97,695,161...97,720,892
G
Rgmb
repulsive guidance molecule BMP co-receptor b
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17568789
NCBI chr 1:56,766,598...56,792,396
Ensembl chr 1:56,767,850...56,792,425
G
RT1-Ba
RT1 class II, locus Ba
ISO
DNA:polymorphisms (human) DNA:polymorphism (human)
RGD
PMID:11482129 PMID:11454644
RGD:5147859 , RGD:5147860
NCBI chr20:4,575,134...4,579,727
Ensembl chr20:4,575,134...4,579,744
G
RT1-Bb
RT1 class II, locus Bb
ISO
DNA:polymorphism (human)
RGD
PMID:11454644
RGD:5147860
NCBI chr20:4,596,558...4,602,201
Ensembl chr20:4,596,559...4,607,597
G
RT1-Db1
RT1 class II, locus Db1
susceptibility
ISO
CTD Direct Evidence: marker/mechanism DNA:polymorphism (human) DNA:polymorphisms (human) DNA:polymorphisms: :multiple (human)
CTD RGD
PMID:19898480 PMID:20453842 PMID:22286218 PMID:18512783 PMID:11454644 PMID:19117368 PMID:21246357 More...
RGD:4144826 , RGD:5147860 , RGD:5147616 , RGD:5147567
NCBI chr20:4,548,664...4,558,237
Ensembl chr20:4,548,666...4,558,258
G
RT1-Hb-ps1
RT1 class II, locus Hb, pseudogene 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17956852 PMID:22286218
NCBI chr20:4,775,598...4,779,590
Ensembl chr20:4,774,650...4,780,618
G
Runx1
RUNX family transcription factor 1
no_association
ISO
DNA:SNPs: :rs2242720, rs4816502 (human) DNA:SNP:intron:24658G>C (human) DNA:SNP: :rs2268277 (human) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:23143596 PMID:20018071 PMID:16821265 PMID:18328148 PMID:18087673
RGD:6482836 , RGD:6482837 , RGD:6482839 , RGD:6482840
NCBI chr11:31,839,880...32,074,427
Ensembl chr11:31,843,764...32,074,542
G
Runx2
RUNX family transcription factor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20008919
NCBI chr 9:16,167,504...16,492,826
Ensembl chr 9:16,167,482...16,492,167
G
Sema3c
semaphorin 3C
ISO
protein:increased expression:knee, synovium (human)
RGD
PMID:15077297
RGD:1580084
NCBI chr 4:17,583,212...17,747,234
Ensembl chr 4:17,583,212...17,746,534
G
Slc11a1
solute carrier family 11 member 1
severity
ISO
DNA:polymorphism:promoter (human) CTD Direct Evidence: marker/mechanism DNA:polymorphisms, deletion: :823C>T, p.D543N (human)
CTD RGD
PMID:16597321 PMID:12135431 PMID:10719815
RGD:5684967 , RGD:5684971
NCBI chr 9:75,957,193...75,968,115
Ensembl chr 9:75,957,316...75,968,101
G
Slc22a4
solute carrier family 22 member 4
susceptibility
ISO
ClinVar Annotator: match by term: Rheumatoid arthritis | ClinVar Annotator: match by term: SLC22A4-related condition CTD Direct Evidence: marker/mechanism
OMIM ClinVar CTD
PMID:14608356 PMID:19881261 PMID:25741868 PMID:26467025 PMID:28492532
NCBI chr10:38,133,333...38,179,932
Ensembl chr10:38,133,322...38,179,720
G
Slc25a12
solute carrier family 25 member 12
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12833524
NCBI chr 3:56,097,166...56,191,841
Ensembl chr 3:56,097,269...56,192,100
G
Sms
spermine synthase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19192274
NCBI chr X:37,516,949...37,572,657
Ensembl chr X:37,516,931...37,570,822
G
Sod2
superoxide dismutase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12833524 PMID:15292528 PMID:24313545
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
G
Spp1
secreted phosphoprotein 1
ISO
RGD
PMID:15761492
RGD:1581382
NCBI chr14:5,308,885...5,315,120
Ensembl chr14:5,308,885...5,315,162
G
Spred2
sprouty-related, EVH1 domain containing 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20453842 PMID:23143596
NCBI chr14:94,149,210...94,250,787
Ensembl chr14:94,148,837...94,249,162
G
St6galnac5
ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17379860 PMID:17568789
NCBI chr 2:241,741,933...241,911,214
Ensembl chr 2:241,742,688...241,911,208
G
Stat1
signal transducer and activator of transcription 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12833524
NCBI chr 9:49,419,561...49,459,969
Ensembl chr 9:49,419,340...49,588,540
G
Stat3
signal transducer and activator of transcription 3
ISO
associated with T-cell large granular lymphocyte leukemia
RGD
PMID:22591296
RGD:6892936
NCBI chr10:85,811,206...85,863,057
Ensembl chr10:85,811,218...85,863,057
G
Stat4
signal transducer and activator of transcription 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20453842 PMID:23143596
NCBI chr 9:49,472,660...49,588,540
Ensembl chr 9:49,419,340...49,588,540
G
Sts
steroid sulfatase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19192274
NCBI chr X:42,225,131...42,233,403
Ensembl chr X:42,225,372...42,233,402
G
Supt20h
SPT20 homolog, SAGA complex component
ISO
ClinVar Annotator: match by term: Rheumatoid arthritis
ClinVar
NCBI chr 2:138,897,316...138,930,493
Ensembl chr 2:138,897,416...138,930,495
G
Tab2
TGF-beta activated kinase 1/MAP3K7 binding protein 2
ISO
mRNA, protein:increased expression:synovial (human)
RGD
PMID:22660635
RGD:155663483
NCBI chr 1:2,375,026...2,425,115
Ensembl chr 1:2,375,490...2,424,756
G
Tab3
TGF-beta activated kinase 1 (MAP3K7) binding protein 3
ISO
mRNA, protein:increased expression:synovial (human)
RGD
PMID:22660635
RGD:155663483
NCBI chr X:49,972,414...50,044,658
Ensembl chr X:49,972,330...50,042,056
G
Tagap
T-cell activation RhoGTPase activating protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20453842 PMID:23143596
NCBI chr 1:47,170,725...47,179,705
Ensembl chr 1:47,170,725...47,179,792
G
Tap2
transporter 2, ATP binding cassette subfamily B member
ISO
RGD
PMID:9645419
RGD:6482275
NCBI chr20:4,636,347...4,650,387
Ensembl chr20:4,636,357...4,650,407
G
Tfpi2
tissue factor pathway inhibitor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15292528 PMID:17379860
NCBI chr 4:31,981,786...31,986,707
Ensembl chr 4:31,982,178...31,986,600
G
Thbd
thrombomodulin
ISO
RGD
PMID:15700117
RGD:5685020
NCBI chr 3:135,863,366...135,867,018
Ensembl chr 3:135,862,835...135,867,193
G
Tle3
TLE family member 3, transcriptional corepressor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23143596
NCBI chr 8:61,857,791...61,903,505
Ensembl chr 8:61,858,200...61,903,493
G
Tlr1
toll-like receptor 1
ISO
ClinVar Annotator: match by term: Rheumatoid arthritis
ClinVar
PMID:32594150
NCBI chr14:43,384,127...43,396,765
Ensembl chr14:43,384,932...43,397,125
G
Tlr2
toll-like receptor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19192274
NCBI chr 2:169,200,620...169,206,819
Ensembl chr 2:169,197,419...169,206,630
G
Tmpo
thymopoietin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12833524
NCBI chr 7:25,642,752...25,667,756
Ensembl chr 7:25,586,725...25,667,727
G
Tnf
tumor necrosis factor
treatment no_association
ISO ISS
OMIM:180300 mRNA:increased expression:synovial (human) CTD Direct Evidence: marker/mechanism|therapeutic DNA:SNP:promoter:-238G>A, -308G>A (human) DNA:SNP:promoter:-857C>T (human)
MouseDO CTD RGD
PMID:2001072 PMID:8391952 PMID:12566094 PMID:22450443 PMID:34459104 PMID:12563673 PMID:22660635 PMID:25311255 PMID:25311255 More...
RGD:10450537 , RGD:155663483 , RGD:12904065 , RGD:12904065
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Tnfaip2
TNF alpha induced protein 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19192274
NCBI chr 6:130,476,832...130,489,914
Ensembl chr 6:130,476,889...130,489,914
G
Tnfaip3
TNF alpha induced protein 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18794853 PMID:20453842 PMID:21841782 PMID:23143596 PMID:30224649
NCBI chr 1:13,709,211...13,724,291
Ensembl chr 1:13,709,206...13,725,282
G
Tnfrsf11b
TNF receptor superfamily member 11B
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:23333834
NCBI chr 7:85,566,520...85,594,526
Ensembl chr 7:85,566,520...85,594,538
G
Tnfrsf14
TNF receptor superfamily member 14
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20453842
NCBI chr 5:165,486,069...165,494,421
Ensembl chr 5:165,484,262...165,493,703
G
Tnfrsf1a
TNF receptor superfamily member 1A
treatment
ISO
DNA:SNP:promoter:36G>A (human)
RGD
PMID:25311255
RGD:12904065
NCBI chr 4:158,150,815...158,163,592
Ensembl chr 4:158,150,820...158,163,591
G
Tnfsf14
TNF superfamily member 14
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20008919
NCBI chr 9:2,068,295...2,073,128
Ensembl chr 9:2,069,104...2,073,216
G
Traf1
TNF receptor-associated factor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18794853 PMID:23143596
NCBI chr 3:18,222,024...18,242,163
Ensembl chr 3:18,222,054...18,241,807
G
Traf6
TNF receptor associated factor 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20453842 PMID:23143596
NCBI chr 3:87,963,517...87,988,316
Ensembl chr 3:87,963,514...87,983,507
G
Trem1
triggering receptor expressed on myeloid cells 1
treatment
IEP
RGD
PMID:27049384
RGD:127229930
NCBI chr 9:12,763,819...12,779,285
Ensembl chr 9:12,763,819...12,779,203
G
Txndc5
thioredoxin domain containing 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23326410
NCBI chr17:26,289,880...26,318,025
Ensembl chr17:26,289,880...26,318,025
G
Txnip
thioredoxin interacting protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19192274
NCBI chr 2:184,093,079...184,096,882
Ensembl chr 2:184,092,991...184,096,886
G
Tyk2
tyrosine kinase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23143596 PMID:30224649
NCBI chr 8:19,641,881...19,667,157
Ensembl chr 8:19,641,884...19,667,044
G
Tyms
thymidylate synthetase
treatment
ISO
DNA:polymorphism: :
RGD
PMID:22763757
RGD:11075093
NCBI chr 9:113,313,454...113,329,551
Ensembl chr 9:113,313,452...113,329,536
G
Tyrobp
transmembrane immune signaling adaptor Tyrobp
treatment
IEP
RGD
PMID:27049384
RGD:127229930
NCBI chr 1:85,672,931...85,676,856
Ensembl chr 1:85,672,994...85,676,848
G
Vdr
vitamin D receptor
no_association
ISO
DNA:SNP:exon:rs2228570 (human) DNA:SNP: :rs1544410 (human)
RGD
PMID:21820934 PMID:21820934
RGD:8158077 , RGD:8158077
NCBI chr 7:128,987,981...129,037,677
Ensembl chr 7:128,987,981...129,037,677
G
Vegfa
vascular endothelial growth factor A
disease_progression
ISO
protein:increased expression:serum: CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:16368150 PMID:24387171
RGD:8548659
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
G
Vim
vimentin
ISO
RGD
PMID:21792832
RGD:6480508
NCBI chr17:76,668,701...76,677,186
Ensembl chr17:76,668,647...76,677,187
G
Zap70
zeta chain of T cell receptor associated protein kinase 70
ISS
OMIM:180300
MouseDO
NCBI chr 9:38,989,750...39,011,701
Ensembl chr 9:38,989,750...39,011,700
G
Zfp36
zinc finger protein 36
ISS
OMIM:180300
MouseDO
NCBI chr 1:83,669,084...83,671,564
Ensembl chr 1:83,669,084...83,671,564
G
Hgf
hepatocyte growth factor
ISO
protein:increased expression:serum:
RGD
PMID:24387171
RGD:8548659
NCBI chr 4:18,673,736...18,745,582
Ensembl chr 4:18,677,101...18,745,409
G
Vegfa
vascular endothelial growth factor A
ISO
protein:increased expression:serum:
RGD
PMID:24387171
RGD:8548659
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
G
RT1-Db1
RT1 class II, locus Db1
susceptibility
ISO
DNA:polymorphism: :HLA-DRB1*1104, HLA-DRB1*080(human)
RGD
PMID:7955632
RGD:7365102
NCBI chr20:4,548,664...4,558,237
Ensembl chr20:4,548,666...4,558,258
G
Acp3
acid phosphatase 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr 8:104,905,570...104,956,146
Ensembl chr 8:104,905,586...104,954,236
G
Acrbp
acrosin binding protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr 4:157,851,149...157,864,211
Ensembl chr 4:157,841,841...157,864,213
G
Adcy7
adenylate cyclase 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr19:18,740,875...18,798,924
Ensembl chr19:18,740,875...18,776,311
G
Alox12
arachidonate 12-lipoxygenase, 12S type
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr10:54,958,263...54,970,542
Ensembl chr10:54,958,271...54,970,542
G
Ankrd9
ankyrin repeat domain 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr 6:130,001,914...130,008,792
Ensembl chr 6:129,998,486...130,008,923
G
Aopep
aminopeptidase O
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr17:1,811,281...2,127,316
Ensembl chr17:1,811,980...2,127,331
G
Aqp9
aquaporin 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr 8:71,797,231...71,837,485
Ensembl chr 8:71,797,234...71,837,395
G
Areg
amphiregulin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr14:16,972,185...16,981,443
Ensembl chr14:16,972,187...16,981,535
G
Asap1
ArfGAP with SH3 domain, ankyrin repeat and PH domain 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr 7:95,786,130...96,093,111
Ensembl chr 7:95,787,818...96,092,754
G
Avl9
AVL9 cell migration associated
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr 4:85,961,493...86,008,347
Ensembl chr 4:85,961,635...86,008,791
G
B4galt5
beta-1,4-galactosyltransferase 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr 3:156,018,056...156,033,983
Ensembl chr 3:156,018,053...156,070,074
G
Bend2
BEN domain containing 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr X:33,401,122...33,465,427
G
Bltp3b
bridge-like lipid transfer protein family member 3B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr 7:24,181,635...24,261,720
Ensembl chr 7:24,181,644...24,261,720
G
Btg1
BTG anti-proliferation factor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr 7:31,341,391...31,343,649
Ensembl chr 7:31,341,027...31,343,649
G
Btg3
BTG anti-proliferation factor 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr11:17,030,156...17,046,069
Ensembl chr11:17,030,160...17,046,170
G
C8b
complement C8 beta chain
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:7980680
NCBI chr 5:119,535,009...119,572,565
Ensembl chr 5:119,535,146...119,572,565
G
C9h2orf88
similar to human chromosome 2 open reading frame 88
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr 9:48,539,140...48,584,882
Ensembl chr 9:48,568,409...48,584,831
G
Cald1
caldesmon 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr 4:63,265,781...63,446,938
Ensembl chr 4:63,265,942...63,446,932
G
Camsap1
calmodulin regulated spectrin-associated protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr 3:8,746,176...8,806,067
Ensembl chr 3:8,746,176...8,806,072
G
Ccdc122
coiled-coil domain containing 122
ISO
ClinVar Annotator: match by term: JUVENILE ARTHRITIS
ClinVar
PMID:25741868
NCBI chr15:52,407,717...52,470,163
Ensembl chr15:52,407,717...52,470,163
G
Ccr5
C-C motif chemokine receptor 5
no_association
ISO
DNA:frameshift mutation:cds:p.S185_T195del rs333 (human) DNA:polymorphisms: :multiple (human)
RGD
PMID:17565662 PMID:16775617
RGD:1626283 , RGD:1626284
NCBI chr 8:123,752,423...123,757,538
Ensembl chr 8:123,752,325...123,759,260
G
Cd14
CD14 molecule
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr18:28,335,522...28,337,383
Ensembl chr18:28,335,340...28,337,261
G
Cd83
CD83 molecule
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr17:20,887,309...20,907,009
Ensembl chr17:20,887,309...20,907,083
G
Cd8b
CD8 subunit beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr 4:103,312,596...103,328,523
Ensembl chr 4:103,312,578...103,328,553
G
Ciita
class II, major histocompatibility complex, transactivator
susceptibility no_association
ISO
DNA:polymorphism:exon:1614G>C (human) DNA:polymorphism:promoter:rs3087456, no association in a German cohort (Human)
RGD
PMID:17661914 PMID:16426246
RGD:5491187 , RGD:5491189
NCBI chr10:5,139,947...5,187,493
Ensembl chr10:5,140,178...5,187,440
G
Clu
clusterin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr15:40,161,068...40,200,315
Ensembl chr15:40,174,617...40,200,315
G
Cmtm2b
CKLF-like MARVEL transmembrane domain containing 2B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr19:640,838...651,872
Ensembl chr19:640,824...651,939
G
Crem
cAMP responsive element modulator
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr17:54,238,889...54,305,989
Ensembl chr17:54,239,030...54,305,989
G
Crp
C-reactive protein
ISO
protein:increased expression:serum
RGD
PMID:22885951
RGD:6906884
NCBI chr13:85,135,384...85,175,178
Ensembl chr13:85,124,977...85,175,178
G
Ctla4
cytotoxic T-lymphocyte-associated protein 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr 9:62,318,874...62,325,978
Ensembl chr 9:62,319,312...62,324,963
G
Cttn
cortactin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr 1:199,599,710...199,635,254
Ensembl chr 1:199,599,710...199,635,164
G
Cxcl1
C-X-C motif chemokine ligand 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr14:17,193,364...17,195,143
Ensembl chr14:17,193,365...17,195,215
G
Cxcl3
C-X-C motif chemokine ligand 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr14:17,287,727...17,289,451
Ensembl chr14:17,270,146...17,289,511
G
Cxcr2
C-X-C motif chemokine receptor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr 9:75,729,493...75,735,868
Ensembl chr 9:75,729,115...75,739,425
G
Cxcr4
C-X-C motif chemokine receptor 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504 PMID:26387944
NCBI chr13:40,077,976...40,081,883
Ensembl chr13:40,077,976...40,081,883
G
Dapk1
death associated protein kinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr17:3,930,223...4,090,991
Ensembl chr17:3,930,213...4,090,991
G
Ddit3
DNA-damage inducible transcript 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
G
Dusp1
dual specificity phosphatase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr10:16,680,478...16,683,275
G
Dusp2
dual specificity phosphatase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr 3:114,556,325...114,558,510
Ensembl chr 3:114,556,325...114,558,499
G
Dusp4
dual specificity phosphatase 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr16:57,376,659...57,398,161
Ensembl chr16:57,377,229...57,398,138
G
Dysf
dysferlin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr 4:116,490,877...116,690,709
Ensembl chr 4:116,490,616...116,690,709
G
Egf
epidermal growth factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr 2:218,219,408...218,302,359
Ensembl chr 2:218,219,415...218,302,064
G
Egr1
early growth response 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr18:26,462,967...26,466,766
Ensembl chr18:26,462,981...26,466,766
G
Elf2
E74 like ETS transcription factor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr 2:135,292,291...135,385,942
Ensembl chr 2:135,294,906...135,385,947
G
Etnk1
ethanolamine kinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr 4:176,126,056...176,170,325
Ensembl chr 4:176,126,180...176,193,770
G
Etv6
ETS variant transcription factor 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr 4:166,849,031...167,085,211
Ensembl chr 4:166,847,686...167,084,992
G
Fam20a
FAM20A, golgi associated secretory pathway pseudokinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr10:94,638,836...94,697,814
Ensembl chr10:94,642,850...94,697,672
G
Faxdc2
fatty acid hydroxylase domain containing 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr10:42,245,808...42,271,679
Ensembl chr10:42,246,868...42,271,871
G
Fcgr1a
Fc gamma receptor 1A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr 2:183,851,075...183,860,077
Ensembl chr 2:183,851,077...183,859,994
G
Fchsd2
FCH and double SH3 domains 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr 1:155,444,471...155,685,350
Ensembl chr 1:155,444,460...155,685,539
G
Fos
Fos proto-oncogene, AP-1 transcription factor subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
G
Fosb
FosB proto-oncogene, AP-1 transcription factor subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr 1:78,954,312...78,961,492
Ensembl chr 1:78,954,115...78,961,465
G
Fosl2
FOS like 2, AP-1 transcription factor subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr 6:24,297,898...24,319,219
Ensembl chr 6:24,300,956...24,320,034
G
Foxp1
forkhead box P1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr 4:131,559,599...132,155,092
Ensembl chr 4:131,564,756...132,112,258
G
Gadd45a
growth arrest and DNA-damage-inducible, alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr 4:96,154,789...96,157,091
Ensembl chr 4:96,154,789...96,157,115
G
Gmpr
guanosine monophosphate reductase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr17:19,151,820...19,189,626
Ensembl chr17:19,151,815...19,189,621
G
Gng11
G protein subunit gamma 11
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr 4:32,023,003...32,028,443
Ensembl chr 4:32,023,003...32,028,442
G
Gp1bb
glycoprotein Ib platelet subunit beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr11:82,378,216...82,379,393
Ensembl chr11:82,378,199...82,379,392
G
Gstt1
glutathione S-transferase theta 1
susceptibility
ISO
DNA:deletion: :
RGD
PMID:18328165
RGD:5490992
NCBI chr20:12,856,613...12,873,586
Ensembl chr20:12,856,669...12,873,585
G
H2bc8
H2B clustered histone 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr17:42,708,658...42,709,408
G
Hbegf
heparin-binding EGF-like growth factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr18:28,106,284...28,116,167
Ensembl chr18:28,105,760...28,116,441
G
Herpud2
HERPUD family member 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr 8:23,573,374...23,618,380
Ensembl chr 8:23,573,379...23,617,874
G
Hfe
homeostatic iron regulator
ISO
DNA:missense mutation:cds:p.C282Y (human)
RGD
PMID:16047841
RGD:8694357
NCBI chr17:41,413,451...41,421,502
Ensembl chr17:41,413,451...41,421,502
G
Hist1h2af
histone cluster 1 H2A family member F
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr17:41,379,404...41,379,796
Ensembl chr17:41,379,404...41,379,796
G
Hspa6l-ps1
heat shock protein family A (Hsp70) member 6 like, pseudogene 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr13:83,273,176...83,274,317
G
Hspd1
heat shock protein family D (Hsp60) member 1
ISO
protein:increased expression:serum,synovial fluid:
RGD
PMID:8255671
RGD:12910480
NCBI chr 9:56,579,195...56,590,011
Ensembl chr 9:56,579,201...56,589,662
G
Igf1r
insulin-like growth factor 1 receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr 1:121,549,831...121,838,548
Ensembl chr 1:121,550,743...121,831,777
G
Il1a
interleukin 1 alpha
ISO
DNA:SNP:promoter:-889C>T (human)
RGD
PMID:8162643
RGD:7794716
NCBI chr 3:116,526,601...116,537,055
Ensembl chr 3:116,526,604...116,536,822
G
Il1rn
interleukin 1 receptor antagonist
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr 3:7,111,567...7,127,451
Ensembl chr 3:7,111,550...7,127,445
G
Il2
interleukin 2
ISO
protein:increased expression:mononuclear cell
RGD
PMID:21859687
RGD:5147870
NCBI chr 2:120,004,862...120,009,566
Ensembl chr 2:120,004,862...120,009,566
G
Il6
interleukin 6
ISO
protein:increased expression:serum:
RGD
PMID:9489833
RGD:7829742
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Itga2b
integrin subunit alpha 2b
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr10:87,408,532...87,426,055
Ensembl chr10:87,408,536...87,426,168
G
Itgb5
integrin subunit beta 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr11:66,828,428...66,944,231
Ensembl chr11:66,829,285...66,944,472
G
Jmjd1c
jumonji domain containing 1C
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr20:21,332,147...21,494,220
Ensembl chr20:21,332,147...21,463,122
G
Jun
Jun proto-oncogene, AP-1 transcription factor subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
G
Kat6b
lysine acetyltransferase 6B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr15:2,638,885...2,811,977
Ensembl chr15:2,639,200...2,812,316
G
Kcnj15
potassium inwardly-rectifying channel, subfamily J, member 15
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr11:34,577,397...34,621,725
Ensembl chr11:34,577,363...34,621,952
G
Klf4
KLF transcription factor 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr 5:70,278,843...70,283,751
Ensembl chr 5:70,278,972...70,283,602
G
Kras
KRAS proto-oncogene, GTPase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr 4:178,185,418...178,218,484
G
Lacc1
laccase domain containing 1
ISO
ClinVar Annotator: match by term: JUVENILE ARTHRITIS
OMIM ClinVar
PMID:25147203 PMID:25220867 PMID:25741868 PMID:27881174 PMID:29717096 PMID:31811059 More...
NCBI chr15:52,390,267...52,407,630
Ensembl chr15:52,395,183...52,407,545
G
Lilra5
leukocyte immunoglobulin like receptor A5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr 1:69,973,292...69,978,750
Ensembl chr 1:69,973,292...70,001,718
G
Lpp
LIM domain containing preferred translocation partner in lipoma
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr11:75,787,326...76,426,646
Ensembl chr11:75,797,078...76,422,597
G
Mad1l1
mitotic arrest deficient 1 like 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr12:14,320,892...14,630,750
Ensembl chr12:14,320,892...14,630,703
G
Maff
MAF bZIP transcription factor F
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr 7:110,912,367...110,923,711
Ensembl chr 7:110,912,499...110,923,851
G
Maml2
mastermind-like transcriptional coactivator 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr 8:10,268,611...10,588,307
Ensembl chr 8:10,268,665...10,587,107
G
Map2
microtubule-associated protein 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr 9:67,723,422...67,981,886
Ensembl chr 9:67,723,371...67,979,809
G
Mapk1
mitogen activated protein kinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
G
Mbl2
mannose binding lectin 2
ISO
RGD
PMID:18334024
RGD:12910845
NCBI chr 1:228,016,439...228,024,736
G
Mex3c
mex-3 RNA binding family member C
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr18:67,167,600...67,188,595
Ensembl chr18:67,166,718...67,188,595
G
Ms4a4a
membrane spanning 4-domains A4A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr 1:208,060,507...208,085,121
Ensembl chr 1:208,046,971...208,085,119
G
Msn
moesin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr X:60,996,043...61,064,011
Ensembl chr X:60,995,951...61,065,628
G
Mtss1
MTSS I-BAR domain containing 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr 7:90,488,751...90,628,007
Ensembl chr 7:90,488,754...90,627,968
G
Myzap
myocardial zonula adherens protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr 8:72,155,817...72,243,036
Ensembl chr 8:72,131,530...72,243,036
G
Ndel1
nudE neurodevelopment protein 1-like 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr10:53,505,628...53,582,025
Ensembl chr10:53,516,491...53,570,907
G
Nr4a2
nuclear receptor subfamily 4, group A, member 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr 3:41,689,847...41,707,036
Ensembl chr 3:41,689,851...41,697,877
G
Nr4a3
nuclear receptor subfamily 4, group A, member 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr 5:62,361,588...62,401,489
Ensembl chr 5:62,361,822...62,402,733
G
Nrg1
neuregulin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr16:59,250,658...60,304,519
Ensembl chr16:59,250,854...60,296,884
G
Olr1
oxidized low density lipoprotein receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr 4:162,926,436...162,949,057
Ensembl chr 4:162,926,439...162,948,523
G
Osm
oncostatin M
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr14:79,103,638...79,108,500
Ensembl chr14:79,104,344...79,108,313
G
Pacsin2
protein kinase C and casein kinase substrate in neurons 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr 7:114,505,525...114,599,087
Ensembl chr 7:114,505,152...114,598,546
G
Pcyt1b
phosphate cytidylyltransferase 1B, choline
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr X:58,378,090...58,471,623
Ensembl chr X:58,378,116...58,468,935
G
Per1
period circadian regulator 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr10:53,800,126...53,814,963
Ensembl chr10:53,805,535...53,814,431
G
Pgm5
phosphoglucomutase 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr 1:222,325,638...222,513,434
Ensembl chr 1:222,325,643...222,513,437
G
Plaur
plasminogen activator, urokinase receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr 1:80,053,440...80,068,384
Ensembl chr 1:80,050,324...80,068,595
G
Plk2
polo-like kinase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr 2:41,969,176...41,974,945
Ensembl chr 2:41,969,176...41,974,947
G
Plod2
procollagen lysine, 2-oxoglutarate 5-dioxygenase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr 8:93,084,548...93,167,255
Ensembl chr 8:93,084,513...93,167,255
G
Pros1
protein S
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr11:230,597...311,288
Ensembl chr11:230,696...311,286
G
Ptpn22
protein tyrosine phosphatase, non-receptor type 22
ISO
DNA: snp : cds : rs2476601
RGD
PMID:15934099
RGD:6484550
NCBI chr 2:191,366,761...191,414,782
Ensembl chr 2:191,366,808...191,414,779
G
R3hdm2
R3H domain containing 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr 7:63,212,519...63,340,574
Ensembl chr 7:63,232,346...63,340,540
G
Rasgef1b
RasGEF domain family, member 1B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr14:9,859,512...10,380,044
Ensembl chr14:9,860,247...10,379,741
G
Rbm47
RNA binding motif protein 47
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr14:42,053,290...42,191,572
Ensembl chr14:42,154,142...42,189,431
G
Rere
arginine-glutamic acid dipeptide repeats
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr 5:160,765,855...161,097,678
Ensembl chr 5:160,765,934...161,097,677
G
RGD1359108
similar to RIKEN cDNA 3110043O21
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr 5:49,766,340...49,791,434
Ensembl chr 5:49,766,325...49,791,408
G
Rhobtb1
Rho-related BTB domain containing 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr20:19,327,142...19,456,121
Ensembl chr20:19,327,155...19,403,012
G
Rnf103
ring finger protein 103
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr 4:103,526,456...103,542,529
Ensembl chr 4:103,526,502...103,555,919
G
RT1-Ba
RT1 class II, locus Ba
ISO
DNA:polymorphism (human)
RGD
PMID:19811310 PMID:10457895
RGD:5147815 , RGD:5147863
NCBI chr20:4,575,134...4,579,727
Ensembl chr20:4,575,134...4,579,744
G
RT1-Bb
RT1 class II, locus Bb
ISO
DNA:polymorphism (human)
RGD
PMID:10457895
RGD:5147863
NCBI chr20:4,596,558...4,602,201
Ensembl chr20:4,596,559...4,607,597
G
RT1-Db1
RT1 class II, locus Db1
ISO
DNA:polymorphism (human)
RGD
PMID:19908388 PMID:10457895
RGD:5147587 , RGD:5147863
NCBI chr20:4,548,664...4,558,237
Ensembl chr20:4,548,666...4,558,258
G
Selp
selectin P
severity
ISO
protein:increased expression:plasma
RGD
PMID:21124648
RGD:6219006
NCBI chr13:76,476,229...76,511,846
Ensembl chr13:76,476,295...76,511,845
G
Sh2d2a
SH2 domain containing 2A
ISO
RGD
PMID:15129233
RGD:2298870
NCBI chr 2:173,312,253...173,318,810
Ensembl chr 2:173,312,253...173,318,810
G
Sh3bgrl2
SH3 domain binding glutamate-rich protein like 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr 8:84,461,019...84,553,124
Ensembl chr 8:84,461,121...84,551,564
G
Sik1
salt-inducible kinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr20:9,949,407...9,959,036
Ensembl chr20:9,947,396...9,958,991
G
Sipa1l1
signal-induced proliferation-associated 1 like 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr 6:101,839,351...102,118,408
Ensembl chr 6:101,839,404...102,116,950
G
Slc11a1
solute carrier family 11 member 1
ISO
DNA:repeat:promoter (human) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:16597321 PMID:10857800
RGD:5684977
NCBI chr 9:75,957,193...75,968,115
Ensembl chr 9:75,957,316...75,968,101
G
Slc22a16
solute carrier family 22 member 16
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr20:43,972,808...44,068,447
Ensembl chr20:43,972,836...44,065,019
G
Slc26a2
solute carrier family 26 member 2
susceptibility
ISO
DNA:SNPs: :
RGD
PMID:17393463
RGD:13208931
NCBI chr18:54,648,276...54,666,627
Ensembl chr18:54,652,951...54,666,626
G
Slc2a3
solute carrier family 2 member 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr 4:155,960,944...156,026,000
Ensembl chr 4:155,960,946...156,025,472
G
Smad3
SMAD family member 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr 8:64,126,829...64,236,960
Ensembl chr 8:64,110,039...64,236,960
G
Stab1
stabilin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr16:6,330,435...6,360,934
Ensembl chr16:6,330,444...6,360,923
G
Stat3
signal transducer and activator of transcription 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr10:85,811,206...85,863,057
Ensembl chr10:85,811,218...85,863,057
G
Stim1
stromal interaction molecule 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr 1:156,656,246...156,818,777
Ensembl chr 1:156,656,013...156,818,363
G
Tcf7l2
transcription factor 7 like 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr 1:254,785,956...254,978,967
Ensembl chr 1:254,786,091...254,978,967
G
Tfdp1
transcription factor Dp-1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr16:76,162,040...76,200,871
Ensembl chr16:76,162,043...76,200,817
G
Tfpi
tissue factor pathway inhibitor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr 3:69,533,156...69,582,547
Ensembl chr 3:69,533,156...69,576,880
G
Thbd
thrombomodulin
ISO
protein:increased expression:serum
RGD
PMID:15209962
RGD:5685023
NCBI chr 3:135,863,366...135,867,018
Ensembl chr 3:135,862,835...135,867,193
G
Thbs1
thrombospondin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr 3:105,056,293...105,071,445
Ensembl chr 3:105,056,292...105,071,440
G
Tnfaip6
TNF alpha induced protein 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr 3:36,502,250...36,521,652
Ensembl chr 3:36,502,188...36,521,649
G
Tnfaip8
TNF alpha induced protein 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr18:43,183,854...43,299,512
Ensembl chr18:43,183,916...43,299,517
G
Tnfrsf22
tumor necrosis factor receptor superfamily, member 22
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr 1:198,840,452...198,860,713
Ensembl chr 1:198,840,453...198,856,309
G
Tnik
TRAF2 and NCK interacting kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr 2:111,184,352...111,587,993
Ensembl chr 2:111,184,387...111,580,750
G
Treml1
triggering receptor expressed on myeloid cells-like 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr 9:12,635,584...12,642,324
Ensembl chr 9:12,635,590...12,642,347
G
Ttll5
tubulin tyrosine ligase like 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr 6:105,483,091...105,700,920
Ensembl chr 6:105,483,191...105,700,934
G
Tubb2a
tubulin, beta 2A class IIa
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr17:30,796,842...30,800,713
Ensembl chr17:30,747,503...30,800,714
G
Ube2e1
ubiquitin-conjugating enzyme E2E 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr15:7,439,751...7,493,410
Ensembl chr15:7,439,759...7,493,400
G
Ube3c
ubiquitin protein ligase E3C
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr 4:5,648,932...5,749,922
Ensembl chr 4:5,648,690...5,750,011
G
Wasf3
WASP family member 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr12:8,563,805...8,660,799
Ensembl chr12:8,562,062...8,660,751
G
Wwox
WW domain-containing oxidoreductase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr19:42,432,141...43,360,278
Ensembl chr19:42,432,152...43,359,391
G
Zfand3
zinc finger AN1-type containing 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr20:8,083,407...8,279,617
Ensembl chr20:8,082,200...8,279,616
G
Zfc3h1
zinc finger, C3H1-type containing
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr 7:51,008,251...51,064,666
Ensembl chr 7:51,007,984...51,064,661
G
Aire
autoimmune regulator
ISS
OMIM:270150
MouseDO
NCBI chr20:10,636,058...10,651,060
Ensembl chr20:10,636,123...10,651,060
G
Apoe
apolipoprotein E
onset
ISO
DNA:polymorphism:exon:
RGD
PMID:15328426
RGD:7495765
NCBI chr 1:79,353,924...79,357,852
Ensembl chr 1:79,353,916...79,357,932
G
Bdnf
brain-derived neurotrophic factor
severity
ISO
protein:increased expression:serum:
RGD
PMID:18830907
RGD:8657019
NCBI chr 3:96,165,042...96,215,621
Ensembl chr 3:96,165,042...96,215,615
G
Bst2
bone marrow stromal cell antigen 2
ISO
mRNA, protein:increased expression: labial gland, CD19+ B cell, CD4-CD8-CD19-monocyte:
RGD
PMID:30249485
RGD:14398821
NCBI chr16:18,216,605...18,220,979
Ensembl chr16:18,217,407...18,220,979
G
C3
complement C3
ISO
RGD
PMID:17675493
RGD:7401265
NCBI chr 9:2,087,437...2,114,366
Ensembl chr 9:2,087,437...2,114,429
G
Cast
calpastatin
ISO
associated with Lupus Erythematosus, Systemic
RGD
PMID:15540513
RGD:5683622
NCBI chr 2:3,973,112...4,082,658
Ensembl chr 2:3,973,112...4,082,659
G
Ccr5
C-C motif chemokine receptor 5
no_association
ISO
DNA:frameshift mutation: :p.S185_T195del (rs333) (human)
RGD
PMID:12412204 PMID:23773920
RGD:8551796 , RGD:8551818
NCBI chr 8:123,752,423...123,757,538
Ensembl chr 8:123,752,325...123,759,260
G
Ccr7
C-C motif chemokine receptor 7
ISS
OMIM:270150
MouseDO
NCBI chr10:84,098,193...84,108,309
Ensembl chr10:84,097,381...84,108,309
G
Cd40lg
CD40 ligand
ISO
protein:increased expression:salivary ductal epithelium (human)
RGD
PMID:12472667
RGD:11520791
NCBI chr X:135,127,052...135,138,768
Ensembl chr X:135,126,969...135,138,306
G
Crp
C-reactive protein
ISO
associated with Arthritis, Rheumatoid;protein:increased expression:serum:
RGD
PMID:2353152 PMID:16013223
RGD:9491774 , RGD:9491835
NCBI chr13:85,135,384...85,175,178
Ensembl chr13:85,124,977...85,175,178
G
Ctla4
cytotoxic T-lymphocyte-associated protein 4
susceptibility
ISO
DNA:SNPs,haplotype: :+49A/G (rs231775),(rs3087243)(human) mRNA:increased expression:salivary gland:
RGD
PMID:16869018 PMID:12528117
RGD:7421506 , RGD:7421519
NCBI chr 9:62,318,874...62,325,978
Ensembl chr 9:62,319,312...62,324,963
G
Cyp19a1
cytochrome P450, family 19, subfamily a, polypeptide 1
ISS
OMIM:270150
MouseDO
NCBI chr 8:54,552,978...54,580,375
Ensembl chr 8:54,553,165...54,580,758
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
ISO
associated with Arthritis, Rheumatoid;DNA:polymorphism: :4889A>G (human)
RGD
PMID:12590982
RGD:5147747
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
G
Dgkq
diacylglycerol kinase, theta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24097067
NCBI chr14:1,059,125...1,073,131
Ensembl chr14:1,059,170...1,073,131
G
E2f1
E2F transcription factor 1
ISS
OMIM:270150
MouseDO
NCBI chr 3:143,064,535...143,075,362
Ensembl chr 3:143,049,478...143,075,361
G
Fas
Fas cell surface death receptor
ISO ISS
protein:increased expression:serum (human) OMIM:270150 protein:decreased expression:lacrimal gland, lymphocyte (mouse)
MouseDO RGD
PMID:9890678 PMID:9870874 PMID:11157873
RGD:8662410 , RGD:8662451 , RGD:8662436
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
G
Fcgr2a
Fc gamma receptor 2A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24097067
NCBI chr13:83,280,782...83,297,535
Ensembl chr13:83,280,784...83,295,967
G
Gdnf
glial cell derived neurotrophic factor
ISO
RGD
PMID:9853108
RGD:6218983
NCBI chr 2:56,894,022...56,919,935
Ensembl chr 2:56,895,010...56,917,209
G
Gtf2i
general transcription factor II I
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24097066
NCBI chr12:22,400,933...22,476,243
Ensembl chr12:22,401,431...22,476,243
G
Hmox1
heme oxygenase 1
treatment
IEP
RGD
PMID:24941846
RGD:10450595
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
G
Hnrnph1
heterogeneous nuclear ribonucleoprotein H1
ISO
RGD
PMID:19264855
RGD:10054311
NCBI chr10:34,692,868...34,702,849
Ensembl chr10:34,693,555...34,702,846
G
Icam1
intercellular adhesion molecule 1
treatment
ISO
protein:increased expression:salivary gland protein:increased expression:plasma
RGD
PMID:11359451 PMID:21589878 PMID:15037117
RGD:8158122 , RGD:8547705 , RGD:8547696
NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
G
Id3
inhibitor of DNA binding 3
ISS
OMIM:270150
MouseDO
NCBI chr 5:148,372,784...148,374,353
Ensembl chr 5:148,372,762...148,374,349
G
Ifng
interferon gamma
ISO
RGD
PMID:15584966 PMID:28421993
RGD:8142390 , RGD:14975117
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
G
Il10
interleukin 10
ISO
RGD
PMID:12233881
RGD:1580479
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
G
Il12a
interleukin 12A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24097067
NCBI chr 2:152,965,769...152,973,035
Ensembl chr 2:152,965,769...152,972,734
G
Il13
interleukin 13
ISO
protein:increased expression:serum
RGD
PMID:12051401
RGD:8549582
NCBI chr10:37,790,130...37,792,687
Ensembl chr10:37,790,130...37,792,737
G
Il17a
interleukin 17A
ISO
RGD
PMID:21182786
RGD:8696035
NCBI chr 9:23,144,402...23,147,889
Ensembl chr 9:23,144,402...23,147,889
G
Il18
interleukin 18
ISO
protein:increased expression:saliva
RGD
PMID:23906036
RGD:8655918
NCBI chr 8:50,904,630...50,932,887
Ensembl chr 8:50,906,960...50,932,887
G
Il1rn
interleukin 1 receptor antagonist
ISO
DNA:repeats:intron:IVS2+914_1000dup IL1RN*2 (human) protein:increased expression:conjunctiva (human)
RGD
PMID:9646842 PMID:11527941
RGD:8549786 , RGD:8549807
NCBI chr 3:7,111,567...7,127,451
Ensembl chr 3:7,111,550...7,127,445
G
Il2
interleukin 2
ISS
OMIM:270150
MouseDO
NCBI chr 2:120,004,862...120,009,566
Ensembl chr 2:120,004,862...120,009,566
G
Il23r
interleukin 23 receptor
ISO
protein:increased expression:minor salivary gland:
RGD
PMID:22262980
RGD:8549566
NCBI chr 4:96,580,568...96,672,540
Ensembl chr 4:96,580,714...96,674,021
G
Il2ra
interleukin 2 receptor subunit alpha
ISS
OMIM:270150
MouseDO
NCBI chr17:66,849,974...66,898,665
Ensembl chr17:66,849,974...66,898,697
G
Il4
interleukin 4
ISS
OMIM:270150
MouseDO
NCBI chr10:37,771,203...37,776,750
Ensembl chr10:37,771,203...37,776,750
G
Il6
interleukin 6
severity
ISO
protein:increased expression:plasma: DNA:polymorphims:promoter:-174G>C(human)
RGD
PMID:11426023 PMID:11426023
RGD:7829718 , RGD:7829718
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Irak1bp1
interleukin-1 receptor-associated kinase 1 binding protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24097067
NCBI chr 8:83,731,512...83,748,289
Ensembl chr 8:83,731,507...83,748,289
G
Itsn2
intersectin 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24097067
NCBI chr 6:27,616,645...27,727,373
Ensembl chr 6:27,600,406...27,727,124
G
Lta
lymphotoxin alpha
no_association susceptibility
ISO
DNA:SNPs: :multiple (human) DNA:SNP, haplotype:intron: (rs909253) (human) protein:increased expression:saliva, serum
RGD
PMID:20952683 PMID:22294627 PMID:22294627 PMID:20952683
RGD:8548776 , RGD:8548787 , RGD:8548787 , RGD:8548776
NCBI chr20:3,618,853...3,621,324
Ensembl chr20:3,618,853...3,620,859
G
Map3k14
mitogen-activated protein kinase kinase kinase 14
ISS
OMIM:270150
MouseDO
NCBI chr10:88,165,349...88,215,558
Ensembl chr10:88,165,351...88,215,523
G
Mmp3
matrix metallopeptidase 3
ISO
RGD
PMID:19332626
RGD:8693671
NCBI chr 8:4,640,397...4,653,963
Ensembl chr 8:4,640,416...4,653,961
G
Mmp9
matrix metallopeptidase 9
ISO
protein:increased activity:saliva
RGD
PMID:15316122 PMID:9923658
RGD:8547814 , RGD:8547858
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
G
Muc16
mucin 16, cell surface associated
ISO
mRNA, protein:increased expression:conjunctival epithelial cell, tear
RGD
PMID:19122828
RGD:7364772
NCBI chr 8:16,164,531...16,323,126
G
Muc19
mucin 19, oligomeric
ISO ISS
mRNA:decreased expression:conjunctival epithelial cell OMIM:270150
MouseDO RGD
PMID:18184611
RGD:7364736
NCBI chr 7:123,017,896...123,139,053
Ensembl chr 7:123,017,896...123,139,053
G
Muc5ac
mucin 5AC, oligomeric mucus/gel-forming
ISO
mRNA:decreased expression:conjunctival epithelial cell
RGD
PMID:18184611
RGD:7364736
NCBI chr 1:196,864,336...196,896,475
Ensembl chr 1:196,864,336...196,896,475
G
Ncf1
neutrophil cytosolic factor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28135245
NCBI chr12:22,485,382...22,494,647
Ensembl chr12:22,485,451...22,494,646
G
Nefl
neurofilament light chain
ISO
protein:increased expression:CSF (human)
RGD
PMID:32423153
RGD:127284890
NCBI chr15:42,301,920...42,305,793
Ensembl chr15:42,301,916...42,305,793
G
Nfkbia
NFKB inhibitor alpha
ISS ISO
OMIM:270150
MouseDO RGD
PMID:20696914
RGD:126908016
NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
G
Phip
pleckstrin homology domain interacting protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24097067
NCBI chr 8:83,776,802...83,891,192
Ensembl chr 8:83,781,465...83,894,283
G
Pon1
paraoxonase 1
ISO
protein:decreased activity:serum (human)
RGD
PMID:20497955
RGD:8547550
NCBI chr 4:33,294,737...33,325,759
Ensembl chr 4:33,294,722...33,321,360
G
Prdm1
PR/SET domain 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24097067
NCBI chr20:47,959,858...47,981,488
Ensembl chr20:47,959,858...47,981,488
G
Ptpn22
protein tyrosine phosphatase, non-receptor type 22
no_association
ISO
DNA:snp:cds:c.1858C>T (human)
RGD
PMID:16163373 PMID:15933742
RGD:11534998 , RGD:11534999
NCBI chr 2:191,366,761...191,414,782
Ensembl chr 2:191,366,808...191,414,779
G
Pttg1
PTTG1 regulator of sister chromatid separation, securin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24097067
NCBI chr10:27,893,466...27,904,965
Ensembl chr10:27,893,689...27,904,837
G
Reg1a
regenerating family member 1 alpha
ISO
protein:increased expression:minor salivary gland, salivary ductal epithelium (human)
RGD
PMID:19016805
RGD:9850137
NCBI chr 4:110,892,451...110,895,115
Ensembl chr 4:110,892,453...110,895,570
G
Rorc
RAR-related orphan receptor C
ISS
OMIM:270150
MouseDO
NCBI chr 2:182,009,707...182,034,910
Ensembl chr 2:182,009,286...182,034,907
G
RT1-Ba
RT1 class II, locus Ba
susceptibility
ISO
DNA:polymorphism:cds:HLA-DQA1*0101 (human) DNA:polymorphisms::HLA-DQA1*0501,LA-DQA1*0301/2;
RGD
PMID:11555411 PMID:21315052
RGD:5147809 , RGD:7421543
NCBI chr20:4,575,134...4,579,727
Ensembl chr20:4,575,134...4,579,744
G
RT1-Bb
RT1 class II, locus Bb
susceptibility
ISO
DNA:polymorphisms:cds:HLA-DQB1*0201 (human) associated with Chronic Hepatitis C;DNA:polymorphism:cds:HLA-DQB1*02 (human) DNA:polymorphisms, haplotypes:cds:HLA-DQB1*0201, HLA-DQB1*0401, HLA-DQB1*0601 (human)
RGD
PMID:21315052 PMID:17489060 PMID:8468491
RGD:7421543 , RGD:36174022 , RGD:7483566
NCBI chr20:4,596,558...4,602,201
Ensembl chr20:4,596,559...4,607,597
G
RT1-Db1
RT1 class II, locus Db1
susceptibility
ISO
DNA:polymorphism:cds:HLA-DRB1*0301 (human)
RGD
PMID:11555411
RGD:5147809
NCBI chr20:4,548,664...4,558,237
Ensembl chr20:4,548,666...4,558,258
G
Satb1
SATB homeobox 1
ISS
OMIM:270150
MouseDO
NCBI chr 9:4,677,817...4,773,061
Ensembl chr 9:4,680,920...4,753,251
G
Selp
selectin P
ISO
protein:increased expression:plasma
RGD
PMID:19832990
RGD:6478702
NCBI chr13:76,476,229...76,511,846
Ensembl chr13:76,476,295...76,511,845
G
St14
ST14 transmembrane serine protease matriptase
ISS
OMIM:270150
MouseDO
NCBI chr 8:29,540,805...29,581,704
Ensembl chr 8:29,540,811...29,581,517
G
Stat4
signal transducer and activator of transcription 4
susceptibility no_association
ISO
DNA:SNP:intron: (rs7582694) (human) CTD Direct Evidence: marker/mechanism DNA:SNP:intron: (rs7574865) (human)
CTD RGD
PMID:24097066 PMID:24097067 PMID:20535138 PMID:20360187 PMID:18273036
RGD:8661690 , RGD:8661709 , RGD:8661708
NCBI chr 9:49,472,660...49,588,540
Ensembl chr 9:49,419,340...49,588,540
G
Tgfb1
transforming growth factor, beta 1
severity
ISO ISS
OMIM:270150
MouseDO RGD
PMID:9358754 PMID:7554451
RGD:7394829 , RGD:7394845
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
G
Thbs1
thrombospondin 1
ISS
OMIM:270150
MouseDO
NCBI chr 3:105,056,293...105,071,445
Ensembl chr 3:105,056,292...105,071,440
G
Tnf
tumor necrosis factor
treatment
ISO IEP
DNA:polymorphism: :-1031T>C(human)
RGD
PMID:22703762 PMID:24941846
RGD:7394766 , RGD:10450595
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Tnfaip3
TNF alpha induced protein 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24097066 PMID:24097067
NCBI chr 1:13,709,211...13,724,291
Ensembl chr 1:13,709,206...13,725,282
G
Tnfsf13b
TNF superfamily member 13b
ISS
OMIM:270150
MouseDO
NCBI chr16:79,462,406...79,492,888
Ensembl chr16:79,462,402...79,492,693
G
Tnip1
TNFAIP3 interacting protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24097067
NCBI chr10:39,037,048...39,084,328
Ensembl chr10:39,037,058...39,077,625
G
Traf3ip2
Traf3 interacting protein 2
ISS
OMIM:270150
MouseDO
NCBI chr20:43,011,405...43,054,654
Ensembl chr20:43,011,450...43,054,667
G
Vim
vimentin
ISO
RGD
PMID:6352937
RGD:6480477
NCBI chr17:76,668,701...76,677,186
Ensembl chr17:76,668,647...76,677,187
G
Vip
vasoactive intestinal peptide
ISO
RGD
PMID:22059987
RGD:5685375
NCBI chr 1:42,064,878...42,073,219
Ensembl chr 1:42,065,120...42,073,216
G
Gstm1
glutathione S-transferase mu 1
susceptibility
ISO
DNA:deletion: :
RGD
PMID:10616008
RGD:5491001
NCBI chr 2:195,649,845...195,655,402
Ensembl chr 2:195,649,845...195,655,411
G
Ido1
indoleamine 2,3-dioxygenase 1
ISO
RGD
PMID:26914138
RGD:11529541
NCBI chr16:67,430,654...67,442,726
Ensembl chr16:67,430,578...67,442,730
G
Il6
interleukin 6
susceptibility
ISO
CTD Direct Evidence: marker/mechanism
CTD OMIM
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Il6r
interleukin 6 receptor
treatment
ISO
RGD
PMID:18358927
RGD:10402823
NCBI chr 2:175,289,157...175,347,719
Ensembl chr 2:175,298,686...175,347,536
G
Mif
macrophage migration inhibitory factor
susceptibility
ISO
CTD Direct Evidence: marker/mechanism
OMIM CTD
NCBI chr20:12,790,919...12,791,784
Ensembl chr20:12,790,902...12,799,504
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all